US20150238303A1 - Variable thickness vascular treatment device systems and methods - Google Patents
Variable thickness vascular treatment device systems and methods Download PDFInfo
- Publication number
- US20150238303A1 US20150238303A1 US14/709,794 US201514709794A US2015238303A1 US 20150238303 A1 US20150238303 A1 US 20150238303A1 US 201514709794 A US201514709794 A US 201514709794A US 2015238303 A1 US2015238303 A1 US 2015238303A1
- Authority
- US
- United States
- Prior art keywords
- distal
- microguidewire
- catheter
- hypotube
- embolic protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- PWTXBHKXKVSMDI-ZETCQYMHSA-N CC(C)(C)C[C@@](C)(N=O)O Chemical compound CC(C)(C)C[C@@](C)(N=O)O PWTXBHKXKVSMDI-ZETCQYMHSA-N 0.000 description 1
- 0 CCC1[C@](C*)[C@@](C)C[C@]1C Chemical compound CCC1[C@](C*)[C@@](C)C[C@]1C 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/011—Instruments for their placement or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A61F2002/011—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/09—Guide wires
Definitions
- This invention is related generally to the field of intravascular medical devices. Particularly a distal embolic protection device as well as methods for use of the device during neurovascular interventional procedures in the cerebral arterial blood vessels.
- Stroke is the leading cause of long term disability in the United States and the second leading cause of death worldwide with over 4.4 million deaths in a year (1999). 1 There are over 700,000 new strokes every year in the United States. 2 Around 85% of all strokes are acute ischemic strokes caused from a blockage in a blood vessel or a blood clot occluding a blood vessel. 2 In 1996, the FDA approved a thrombolytic drug to dissolve blood clots called recombinant tissue plasminogen activator (r-tpa).
- Intra-arterial infusion of thrombolytic agents can be used for up to 6 hours from acute ischemic stroke symptom onset and could benefit more people.
- Intra-arterial infusion of thrombolytic agents are administered to a blood clot and the blood clot breaks up into smaller blood clots and travel downstream and potentially close up smaller cerebral blood vessels.
- More than 8% of all acute ischemic strokes are from blockages in the cervical or neck carotid artery. 2 Studies have shown that performing percutaneous balloon angioplasty and stenting on these blockages result in emboli or debris being dislodged downstream and could cause further strokes and therefore there have been large clinical trials of angioplasty and stenting of the carotid artery in the neck with distal embolic protection devices being used. 6 In addition to blockages in the neck region of the carotid artery, more than 8% of all acute ischemic strokes are due to blockages in the cerebral arterial blood vessels called intracranial stenosis. 2 Recently there has been a new device approved for intracranial angioplasty and stenting.
- Embolic protection devices have been developed for the cervical carotid artery prior to carotid angioplasty and stenting. 6 However, these devices do not have a small profile for use in the cerebral arterial blood vessels and will not be able to track and traverse the tortuous cerebral arterial blood vessels.
- embolic protection devices Barbut in U.S. Pat. No. 6,165,199 has described embolic protection devices that can be used for the cerebral arterial blood vessels.
- This is a proximal embolic protection device wherein the embolic protection device is before the clot or blockage comprising of a proximal balloon occlusion catheter to create flow arrest and an aspiration device to suction out the emboli or debris during the interventional procedure in the cervical and cerebral blood vessels.
- the drawbacks of a proximal protection device are that the flow arrest performed to decrease emboli or debris from traveling downstream can be detrimental in itself, since creating a flow arrest in an already ischemic blood vessel during the long neurovascular interventional procedures would in itself worsen the cerebral ischemia and worsen the strokes.
- Bose et al in U.S. Pat. No. 6,669,721 describe thin-film distal embolic protection devices that can be potentially used in the cerebral blood vessels.
- the device has one or two rings and a thin-film filter that is attached to the guidewire.
- the drawbacks of this device is that during neurovascular interventional procedures, there is constant exchange of microcatheters, balloon catheters, and stent catheters over the guidewire or microguidewire, and a distal embolic protection device that is rigidly fixed to the guidewire or microguidewire would cause trauma to the cerebral arterial blood vessel wall as there will not be any mobility of the wire independent of the distal embolic protection device.
- 6,544,279 B1 describe distal embolic protection devices that do have mobility over a guidewire or microguidewire, however these guidewires or microguidewires are of uniform thickness and the mobile attachment point in these devices extend through the entire length of the device.
- Current microguidewires used in neurovascular interventional procedures to perform intracranial angioplasty and stenting among other procedures use microguidewires in the thickness of 0.014 inch (0.356 mm).
- Current microcatheters used for intracranial cerebral blood vessel catheterization for stroke as well as during intracranial angioplasty and stenting have an inner diameter of about 0.017 inch (0.432 mm).
- Having a distal embolic protection device mounted on a uniform thickness microguidewire of a thickness of 0.014 inch (0.356 mm) will not permit the distal embolic protection device in the collapsed form to have a thin enough or small enough profile to be compatible with existing microcatheters that are 0.017 inch (0.432 mm) in inner diameter.
- Having a distal embolic protection device mounted on a uniform thickness microguidewire with a mobile attachment point that extends through the entire length of the device will increase the overall thickness of the device in the collapsed configuration thereby limiting the trackability of the device and inhibiting access to the tortuous and narrow cerebral arterial blood vessels.
- the present invention provides a distal embolic protection device that can be used for neurovascular interventional procedures including, but not limited to, intra-arterial thrombolytic or clot dissolving drug infusion for acute ischemic stroke, as well as percutaneous transluminal intracranial balloon angioplasty and stenting procedures for patients at risk for stroke so that the small emboli or debris that are dislodged during these procedures can be retrieved safely.
- the distal embolic protection device of this invention has a thin and small profile such that they are compatible with existing standard microcatheters.
- the distal embolic protection device of this invention is not attached to a balloon or stent.
- the present invention also addresses the limitations of all the prior art on embolic protection devices discussed above as well as those that have been referenced.
- An object of this invention is to have a distal embolic protection device that is dedicated to the cerebral arterial blood vessels and is suitable for use in cerebral arterial blood vessels of 1.5 mm to 4.5 mm in diameter.
- the definition of cerebral arterial blood vessels is described in the detailed description of FIGS. 1 , 2 and 3 .
- Another object of this invention is to have an embolic protection device that does not have to cause flow arrest to provide embolic protection. Devices that cause flow arrest have a risk of worsening a stroke. Therefore the embolic protection device of this invention is distal rather than proximal to the blockage or blood clot and not proximal to the blockage or blood clot.
- Another object of this invention is to have a distal embolic protection device that can pass through the tortuous cerebral arterial blood vessels with no or little trauma to the vessels.
- Current embolic protection devices are transported or moved through catheters using a small stearable microwire. Due to the bulky nature of current embolic protection devices, it is very difficult to navigate through even in straight blood vessels leave alone tortuous blood vessels.
- Another object of this invention is to have a distal embolic protection device comprising a collapsible filtering device that has a small thin profile so that in the collapsed configuration of the filtering device, the thickness of the distal embolic protection device is no more than about 0.017 inch (0.432 mm), preferably no more than about 0.014 inch (0.356 mm), and can be delivered and retrieved via a standard microcatheter (inner diameter of 0.017 inch, 0.432 mm), a balloon catheter or stent catheter that are used in neurovascular interventional procedures.
- the filtering device is not attached to a balloon or stent.
- variable thickness microguidewire comprises a thinner segment bordered on both ends by thicker segments.
- the thinner segment is no more than about 0.010 inches in thickness and preferably about 0.008 to 0.010 inch (0.203 to 0.254 mm).
- the thicker segments, which make up the majority of the microguidewire, are thicker than the thinner segment and preferably no more than 0.017 inch (0.432 mm) in thickness, more preferably no more than about 0.014 inch (0.356 mm).
- the variable thickness microguidewire may comprise a core microguidewire that extends through the entire length, or a portion of, of the microguidewire and a coating or covering or flexible hypotube or a combination thereof over the core microguidewire.
- the filtering device is mounted on the thinner segment, which is in the distal segment of the microguidewire to maintain a small thin profile so that trackability is maintained as well as compatibility with existing microcatheters, balloon catheters and stent catheters that are used in neurovascular interventional procedures.
- the small thin profile is no more than about 0.017 inch (0.432 mm) and more preferably no more than about 0.014 inch (0.356 mm).
- Another object of this invention is a distal embolic protection device comprising a variable thickness microguidewire and a filtering device, wherein the microguidewire and filtering device have rotational and longitudinal movement relative to and independently of each other, such that the filtering device can remain stable within the blood vessel while there is motion on the microguidewire both in the rotational as well as longitudinal directions relative to the filtering device so that there is no, or very limited, trauma to the fragile cerebral arterial blood vessels.
- the filtering device of the distal embolic protection device of this invention may comprise mobile attachment points on its proximal and distal ends wherein the mobile attachment points attach the filtering device to the microguidewire.
- the mobile attachment points are of such a size that that the thickness of the filtering device in the collapsed configuration is smaller than a cerebral arterial blood vessel and can pass through standard microcatheters that are used in neurovascular interventional procedures.
- the attachment points in conjunction with the filtering device in the collapsed configuration are no more than about 0.017 in (0.432 mm), and more preferably not more than about 0.014 inch (0.356 mm) in thickness.
- the attachment points are short and abut, but do not cover, the thicker segments of the microguidewire.
- the distal embolic protection device comprises a filtering device rotatably mounted on the thinner segment of the microguidewire, and further comprises cylindrical coils that wind around the thinner segment of the microguidewire and connect the proximal and distal ends of the filtering device to the proximal and distal stops of the thicker segments of the microguidewire.
- the attached cylindrical coils decrease the shear stress on the thinner segment of the microguidewire during the retrieval of the distal embolic protection device.
- the distal embolic protection device comprises a radio-opaque portion that enables the device to be visualized during fluoroscopic neurovascular interventional procedures.
- the thicker segments of the microguidewire, or the distal end of the microguidewire, or the filtering device itself may comprise radio-opaque sections so that the operator during a medical procedure can distinguish the filtering device and its position relative to the thicker and thinner segments of the microguidewire.
- the distal embolic protection devices of this invention are dedicated to use in cerebral arterial blood vessels and their use in the treatment of existing stroke patients and patients that are at risk for strokes.
- the methods of this invention include e.g., crossing a vascular blockage or blood clot with a standard microcatheter and microwire. Then removing the microwire and once the microwire is removed, the distal embolic protection device is advanced via the microcatheter to the desired location. As the distal embolic protection device is not involved in navigation, it is able to pass the tortuous curves of the cerebral blood vessels due to the novel delivery system.
- the microguidewire is also designed to be compatible with existing microcatheters, balloon catheters and stent catheters used in neurovascular interventions.
- the stops in the distal part of the microguidewire and the mobile attachment points on the filtering device allow for mobility of the microguidewire both in the rotatory and longitudinal directions relative to the filtering device, wherein the filtering device is stable in the cerebral blood vessel thereby minimizing vessel trauma or dissections.
- the variable thickness of the distal part of the microguidewire also allows for the smaller overall profile of the device and improves its compatibility with existing microcatheters, balloon catheters, and stent catheters.
- the small profile also allows for easy retrieval of the distal embolic protection device of this invention using existing microcatheters, balloon catheters or stent catheters making the procedure shorter and safer.
- the methods of this invention for collecting thrombo-embolic material, debris or clots released during percutaneous neurovascular interventional procedures specifically performed in the cerebral arterial blood vessels comprises inserting the distal embolic protection device of this invention into a cerebral arterial blood vessel having an area of stenosis or a clot, deploying the filtering device distal to the area of blockage or clot and allowing the filtering device to expand to fill the diameter of the cerebral arterial blood vessel.
- the methods of this invention may further comprise advancing a standard microcatheter over a standard microwire across the area of stenosis or clot, positioning the microcatheter distal to the stenosis or clot, withdrawing the microwire, and advancing the distal embolic protection device through the standard microcatheter.
- the thickness of the thicker segments of the variable thickness microguidewire is no more than about 0.017 inch (0.432 mm) and preferably no more than about 0.014 inch (0.356 mm) such that it is compatible for use with standard microcatheters, which have an inner lumen diameter of about 0.017 inch (0.432 mm).
- the methods of this invention may further comprise withdrawing the microcatheter, while keeping the microguidewire in position distal to the stenosis or clot, unsheathing the distal embolic protection device and expanding the filtering device to the inside size of the cerebral arterial blood vessel, ranging from 1.5 mm to 4.5 mm, and wherein the expanded shape of the filter membrane is a hemispherical, helical or conical shape and spans the cerebral arterial blood vessel.
- the method may also comprise maintaining the microguidewire in position, exchanging the standard microcatheter for (1) a balloon catheter to perform balloon angioplasty of the cerebral arterial blood vessels, or (2) a stent catheter to perform stenting of the cerebral arterial blood vessels, and collecting any debris or clots that are dislodged during the balloon angioplasty and or stenting in the cerebral arterial blood vessels in the filter membrane.
- the methods of this invention also comprise maintaining the microguidewire in position and administering clot dissolving drugs or thrombolytics to a patient in need thereof through a standard microcatheter, such that any debris or clots that are dislodged will be collected by the filter membrane.
- the methods of this invention may comprise additional steps, e.g., recovering the distal embolic protection device by advancing a standard microcatheter, balloon catheter, or stent catheter over the variable thickness microguidewire, and withdrawing the distal embolic protection device and the standard microcatheter, balloon catheter or stent catheter.
- FIG. 1 is a schematic diagram illustrating the origin of the great vessels from the heart.
- FIG. 2 is a schematic diagram illustrating the cervical and cerebral course of the internal carotid arteries and their branches.
- FIG. 3 is a schematic diagram illustrating the cervical and cerebral course of the vertebral arteries and their branches.
- FIG. 4 is a schematic diagram illustrating the Circle of Willis and the main collateral blood vessel pathways in the brain.
- FIG. 5 illustrates the introducer system for delivery of the distal embolic protection device into the microcatheter.
- FIG. 6 illustrates the introducer sheath and its components.
- FIG. 7A illustrates a magnified cross sectional view of an introducer sheath with the distal embolic protection device comprising the filtering device and variable thickness microguidewire.
- FIG. 7B illustrates a magnified view of the variable-thickness microguidewire with the filtering device mounted on it and shown in a collapsed configuration within the microcatheter.
- FIGS. 8A and 8B illustrate the microguidewires in two lengths 300 cm and 190 cm respectively.
- FIG. 9A is an illustration of the distal segment of the microguidewire (distal 30 cm).
- FIGS. 9B , 9 C and 9 D are magnified views of embodiments of the variable thickness microguidewire with different components of the distal segment of the microguidewire illustrated (distal 30 cm).
- FIG. 10 is an illustration of one of the embodiments of the distal embolic protection device.
- FIG. 11 is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described in FIG. 10 .
- FIG. 12 illustrates one of the embodiments of a distal embolic protection device in the expanded configuration showing the radio-opaque components under fluoroscopy.
- FIG. 13 illustrates another embodiment of a distal embolic protection device over the variable thickness microguidewire.
- FIG. 14A is an illustration of another embodiment of the distal embolic protection device.
- FIG. 14B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described in FIG. 14A .
- FIG. 15A is an illustration of another embodiment of the distal embolic protection device.
- FIG. 15B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described in FIG. 15A .
- FIG. 16 is a schematic diagram illustrating a significant blockage or stenosis 585 in the right middle cerebral artery 105 .
- FIG. 17 is a schematic diagram illustrating a microcatheter being advanced into the right middle cerebral artery over a microwire.
- FIG. 18 is a schematic diagram illustrating the microcatheter has been carefully advanced across the blockage in the right middle cerebral artery over a microwire.
- FIG. 19 is a schematic diagram illustrating the introducer sheath with the non-expanded distal embolic protection device and microguidewire are being advanced through the microcatheter.
- FIG. 20 is a schematic diagram illustrating the distal embolic protection device in the appropriate location distal to the blockage and the microcatheter being withdrawn to deploy the device.
- FIG. 21 is a schematic diagram illustrating the distal embolic protection device fully deployed.
- FIG. 22 is a schematic diagram illustrating intracranial angioplasty being performed using the distal embolic protection device.
- FIG. 23 is a schematic diagram illustrating intracranial stenting being performed using the distal embolic protection device.
- FIG. 24 is a schematic diagram of a standard microcatheter used to recover the distal embolic protection device.
- FIG. 25 is a schematic diagram illustrating the stent catheter or the tip of the standard microcatheter being advanced over the microguidewire to retrieve the distal embolic protection device.
- FIG. 26 is a schematic diagram illustrating the distal embolic protection device being safely retrieved by either the stent catheter or a standard microcatheter.
- FIG. 27 is a schematic diagram illustrating another use for this distal embolic protection device namely during intra-arterial thrombolysis for thrombus or blood clot causing acute ischemic stroke.
- FIG. 28 is a schematic diagram illustrating a standard microcatheter being advanced across the thrombus or blood clot in the right middle cerebral artery over a microwire.
- FIG. 29 is a schematic diagram illustrating a distal embolic protection device being deployed distal to the thrombus or blood clot causing the stroke and then the microcatheter is withdrawn back and intra-arterial thrombolysis is initiated.
- FIG. 30 is a schematic diagram illustrating the retrieval of the distal embolic protection device with the standard microcatheter.
- FIG. 1 is a schematic diagram that illustrates the heart, the aorta and the supra-aortic vessels.
- the left ventricle 5 is one of the chambers of the heart and pumps oxygenated blood to the rest of the body through the aorta 10 .
- the innominate artery 15 is one of the great vessels originating from the aorta 10 and divides into two branches namely the right subclavian artery 20 and the right common carotid artery 25 .
- the right common carotid artery 25 gives off the right internal carotid artery 30 that continues intracranially to supply the anterior circulation or the front of the brain (see FIG. 2 for further details), and the right external carotid artery 35 which continues to supply the scalp, face and neck.
- the right subclavian artery 20 gives off several branches including the right vertebral artery 40 which continues intracranially to supply the posterior circulation or the back of the brain (see FIG. 3 for further details).
- the next great vessel originating from the aorta 10 is the left common carotid artery 45 .
- the left common carotid artery 45 divides into the left internal carotid artery 50 , which continues intracranially to supply the anterior circulation or the front of the brain (see FIG. 2 for further details), and the left external carotid artery 55 , which continues to supply the scalp, face and neck.
- This portion of the aorta 10 from which the left common carotid artery arises is also known as the aortic arch 60 .
- the left subclavian artery 65 arises from the aortic arch 60 and gives off several branches including the left vertebral artery 70 which continues intracranially to supply the posterior circulation or the back of the brain (see FIG. 3 for further details). Subsequent to the origin of the left subclavian artery 65 , the aortic arch curves inferiorly or downwards and is known as the descending aorta 75 which continues to supply the abdomen, spine and lower extremities.
- FIG. 2 is a schematic diagram illustrating the cervical and intracranial course of the internal carotid arteries.
- the right common carotid artery 25 divides into the right external carotid artery 35 and the right cervical internal carotid artery 30 in the neck.
- the right internal carotid artery in the cervical or neck portion 30 enters the base of skull and continues as the petrous portion of the right internal carotid artery 80 .
- the petrous portion of the right internal carotid artery 80 then continues as the tortuous cavernous portion of the right internal carotid artery 85 .
- the right internal carotid artery then pierces the dura or covering layering of the brain to form the supraclinoid portion of the right internal carotid artery 90 and gives off the right posterior communicating artery 95 which helps form the circle of Willis or the collateral pathway to other blood vessels in the brain (see FIG. 4 for further details).
- the supraclinoid portion of the right internal carotid artery 90 then bifurcates 100 into the right middle cerebral artery 105 as well as the right anterior cerebral artery 120 at the right internal carotid artery bifurcation 100 .
- the right middle cerebral artery divides into several branches and the main ones being the right middle cerebral artery superior division 110 and the right middle cerebral artery inferior division 115 .
- the A1 segment of the right anterior cerebral artery 120 further continues as the A2 segment of the right anterior cerebral artery 125 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicating artery 130 that communicates with the blood vessels from the left side of the brain to also form the circle of Willis.
- the left common carotid artery 45 divides into the left external carotid artery 55 and the left cervical internal carotid artery 50 in the neck.
- the left internal carotid artery in the cervical or neck portion 50 enters the base of skull and continues as the petrous portion of the left internal carotid artery 180 .
- the petrous portion of the left internal carotid artery 180 then continues as the tortuous cavernous portion of the left internal carotid artery 175 .
- the left internal carotid artery then pierces the dura or covering layering of the brain to form the supraclinoid portion of the left internal carotid artery 165 and gives off the left posterior communicating artery 170 which helps form the circle of Willis or the collateral pathway to other blood vessels in the brain.
- the supraclinoid portion of the left internal carotid artery 165 then bifurcates 145 into the left middle cerebral artery 150 as well as the left anterior cerebral artery 140 at the left internal carotid artery bifurcation 145 .
- the left middle cerebral artery divides into several branches and the main ones being the left middle cerebral artery superior division 155 and the left middle cerebral artery inferior division 160 .
- the A1 segment of the left anterior cerebral artery 140 further continues as the A2 segment of the left anterior cerebral artery 135 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicating artery 130 that communicates with the blood vessels from the right side of the brain to also form the circle of Willis.
- the internal carotid arteries from the petrous, cavernous and supraclinoid portions and their branches, along with the middle cerebral and anterior cerebral arteries and their branches are considered as cerebral arterial blood vessels ( 80 to 180 ).
- FIG. 3 is a schematic diagram illustrating the course of the bilateral vertebral arteries and their branches.
- the right vertebral artery 40 is a branch of the right subclavian artery 20 .
- the first portion of the right vertebral artery in the cervical or neck portion is called the V1 segment of the right vertebral artery 40 .
- the right vertebral artery continues in the neck as the V2 segment of the right vertebral artery 185 and travels close to the base of brain. It makes a tortuous curve and is called the V3 segment of the right vertebral artery 190 and finally pierces the dura or outer covering layer of the brain and forms the V4 segment of the right vertebral artery 195 .
- the V4 segment of the right vertebral artery 195 gives off an important branch to the right cerebellum called the right posterior-inferior cerebellar artery 200 and then joins together with the V4 segment of the left vertebral artery 255 at the vertebro-basilar junction 205 to form the basilar artery 210 .
- the basilar artery 210 gives off several branches including the bilateral anterior inferior cerebellar arteries 215 and 245 , as well as, the bilateral superior cerebellar arteries 220 and 240 , and then bifurcates at the basilar apex 225 into the bilateral posterior cerebral arteries 230 and 235 .
- the right posterior communicating artery 95 communicates with the right posterior cerebral artery 230 (see FIG. 4 for further details).
- the left posterior communicating artery 170 communicates with the left posterior cerebral artery 235 (see FIG. 4 for further details).
- the left vertebral artery 70 is a branch of the left subclavian artery 65 .
- the first portion of the left vertebral artery in the cervical or neck portion is called the V1 segment of the left vertebral artery 70 .
- the left vertebral artery continues in the neck as the V2 segment of the left vertebral artery 265 and travels close to the base of brain. It makes a tortuous curve and is called the V3 segment of the left vertebral artery 260 and finally pierces the dura or outer covering layer of the brain and forms the V4 segment of the left vertebral artery 255 .
- the V4 segment of the left vertebral artery 255 gives off an important branch to the left cerebellum called the left posterior-inferior cerebellar artery 250 and then joins together with the V4 segment of the right vertebral artery 195 at the vertebro-basilar junction 205 to form the basilar artery 210 .
- the vertebral arteries from the V2, V3, and V4 segments and their branches, along with the basilar artery and the bilateral posterior cerebral arteries and their branches are also considered as cerebral arterial blood vessels ( 185 to 265 ).
- FIG. 4 is a schematic diagram illustrating the main collateral pathways and communications between the cerebral arterial blood vessels including the internal carotid artery system ( 90 to 170 ) as well as the vertebro-basilar artery system ( 205 to 245 ), and this is known as the Circle of Willis.
- the supraclinoid portion of the right internal carotid artery 90 gives off the right posterior communicating artery 95 which anastomoses or communicates with the right posterior cerebral artery 230 and helps form the posterior part of the circle of Willis.
- the supraclinoid portion of the right internal carotid artery 90 then bifurcates 100 into the right middle cerebral artery 105 as well as the right anterior cerebral artery 120 at the right internal carotid artery bifurcation 100 .
- the A1 segment of the right anterior cerebral artery 120 further continues as the A2 segment of the right anterior cerebral artery 125 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicating artery 130 that anastomoses or communicates with the junction of the A1 segment 140 and A2 segments 135 of the left anterior cerebral artery and helps form the anterior part of the circle of Willis.
- the supraclinoid portion of the left internal carotid artery 165 gives off the left posterior communicating artery 170 , which anastomoses or communicates with the left posterior cerebral artery 235 and helps form the posterior part of the circle of Willis.
- the supraclinoid portion of the left internal carotid artery 165 then bifurcates 145 into the left middle cerebral artery 150 as well as the left anterior cerebral artery 140 at the left internal carotid artery bifurcation 145 .
- the A1 segment of the left anterior cerebral artery 140 further continues as the A2 segment of the left anterior cerebral artery 135 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicating artery 130 that communicates with the junction of the A1 segment 120 and A2 segments 125 of the right anterior cerebral artery and helps form the anterior part of the circle of Willis.
- the anterior 130 and posterior communicating arteries 95 and 170 help with the anastomoses or communication of the internal carotid artery system ( 90 to 170 ) with the vertebro-basilar arterial system ( 205 to 245 ) and helps maintain an adequate collateral pathway for blood supply in the brain (see FIG. 2 for further details on the course of the internal carotid arteries and see FIG. 3 for further details on the course of the vertebral arteries).
- FIG. 2 for further details on the course of the internal carotid arteries and see FIG. 3 for further details on the course of the vertebral arteries.
- FIG. 5 illustrates an introducer system to deliver the distal embolic protection device into the microcatheter.
- the microguidewire 290 that contains the distal embolic protection device is housed in a protective spiral polymer case 270 to avoid kinks or bends in the microguidewire.
- the spiral loops of the protective polymer case are kept together by clasps 275 .
- the proximal end of the microguidewire is at the inner end of the spiral polymer case.
- the distal end of the microguidewire with the distal embolic protection device are kept in an introducer sheath 305 that is made out of a polymer (such as Teflon) and the portion of the introducer sheath 310 directly overlying the distal embolic protection device and protecting it is shown in this figure.
- a polymer such as Teflon
- the proximal end of the introducer sheath has a hemostatic valve 295 and a port for attaching a saline flush syringe 300 to be able to saline flush the introducer sheath as well as the distal embolic protection device of any air.
- the distal end of the introducer sheath 315 is the part that helps feed the distal embolic protection device into the microcatheter. When the distal protection device needs to be loaded into the microcatheter, the introducer sheath is removed from the clasps, of the spiral polymer case 275 and the microguidewire is slowly pulled off the distal port of the spiral polymer case 285 .
- FIG. 6 illustrates the introducer sheath 305 as well as the portion of the distal end of the introducer sheath 310 directly overlying the distal embolic protection device and protecting it.
- FIG. 7A illustrates the distal embolic protection device comprising the filtering device in the collapsed configuration 350 that is back loaded into the introducer sheath 305 over the microguidewire.
- FIG. 7B illustrates a magnified view of the distal embolic protection device comprising the filtering device in a collapsed configuration mounted on the variable thickness micro-guidewire.
- the length of the microguidewire is sufficient for use in existing microcatheters during interventional neurovascular procedures and preferably ranges from 190 to 300 cm in length.
- the majority of the proximal 290 and distal 335 microguidewire are around 0.014 inch (0.356 mm) in thickness to be compatible with existing microcatheters, balloons and stents that are used in neurovascular interventions.
- the distal segment of the microguidewire 335 Part of the distal segment of the microguidewire 335 , e.g., 135 cm, is shown in the figure.
- the distal segment of the microguidewire has a thinner segment 360 that is about 0.010 inch (0.254 mm) or less in thickness and this is in the location where the filtering device is mounted.
- the filtering device is depicted in a collapsed configuration 350 .
- the thinner segment 360 of the microguidewire where the filtering device is located is much thinner than the rest of the microguidewire 335 and is no more than about 0.010 inch (0.254 mm) and preferably measures about 0.008 to 0.010 inch (0.203 mm to 0.254 mm) in thickness.
- the thinner segment 360 of the microguidewire meets the thicker segment of the microguidewire at the proximal stop 340 and distal stop 375 .
- the proximal 340 and distal stops 375 are no more than about 0.017 inch (0.432 mm) and preferably range from 0.014 inch to 0.017 of an inch (0.356 mm to 0.432 mm).
- the filtering device 350 has proximal 345 and distal 355 attachment points that allow the filtering device to be mobile over the microguidewire in the rotatory and longitudinal directions, relative to the microguidewire. The movement of the filtering device relative to the microguidewire is limited to within the thinner segment of the microguidewire 360 by the proximal 340 and distal stops 375 .
- the microguidewire distal 365 to the distal stop 375 comprises several components that are further described in FIG.
- the microguidewire may comprise a marker 380 at a predetermined location, e.g. at 135 cm from the distal tip of the microguidewire, to aid in determining when the distal embolic protection device is likely to emerge from the distal end of the microcatheter (normally 135 cm to 175 cm in length) and in determining the progress and location of the distal embolic protection device within the cerebral arterial blood vessel.
- the 135 cm marker is visually detectable by the operator so that fluoroscopy can be avoided till approximately 135 cm of the microguidewire has been advanced through the microcatheter.
- FIGS. 8A and 8B illustrate the components of the microguidewire at two lengths namely an exchange length 300 cm ( FIG. 8A ) and a non-exchange length microguidewire length 190 cm respectively ( FIG. 8B ).
- the microguidewire is of variable thickness at the distal end, having a thinner segment to accommodate a distal embolic protection device.
- the majority of the microguidewire 335 other than the thinner segment, is of thickness no more than about 0.014 inch (0.356 mm) and is compatible for use with existing microcatheters, balloons, and stents used in neurovascular interventions.
- a marking 380 on the microguidewire indicates the 135 cm length so that fluoroscopy can be avoided till approximately 135 cm of the microguidewire has been advanced through the microcatheter.
- the distal segment of the microguidewire comprises a thinner segment 360 having a thickness that is no more than about 0.010 inch (0.254 mm) to accommodate the non-expanded filtering device and still maintain an overall low thickness profile of the distal embolic protection device.
- the microguidewire has a proximal 340 and distal 375 stop that will allow the filtering device to be stationary in a small cerebral arterial blood vessel despite rotatory and longitudinal motion of the microguidewire over a small distance.
- the proximal and distal stops have a thickness of no more than about 0.017 inch (0.432 mm) and preferably from 0.014 to 0.017 inch (0.356-0.432 mm).
- Part of the distal segment of the microguidewire 335 e.g. distal 30 cm comprises several components that are further described in detail in FIGS. 9A to 9D .
- the distal end includes a distal tip 365 which may comprise radio-opaque shapeable material to provide some trackability and to retain a curved shape to avoid small vessel perforation.
- FIG. 8A shows an exchange length microguidewire 300 cm in length.
- FIG. 8B shows a non-exchange length microguidewire 190 cm in length.
- the non-exchange length guidewire has a capability at its proximal end 385 to have an extension microguidewire 390 attached if it needs to be converted into an exchange length microguidewire.
- FIG. 9A is an illustration of an embodiment of the distal segment of the microguidewire e.g. distal 30 cm described in FIG. 8 .
- FIGS. 9B , 9 C and 9 D are magnified views of the various components of the distal segment of the variable thickness microguidewire e.g. distal 30 cm.
- the microguidewire is of variable thickness at the distal segment to accommodate a filtering device at its distal end.
- the majority of the microguidewire 335 is no more than about 0.014 inch (0.356 mm) in thickness, and is compatible with existing microcatheters, balloons, and stents used in neurovascular interventions.
- the microguidewire 335 comprises various components including a core microguidewire 334 that runs the entire length of the microguidewire and provides support and trackability that is need for catheterization of the small cerebral arterial blood vessels.
- the core microguidewire comprises of a metal e.g. stainless steel or an alloy e.g nickel-titanium.
- the core microguidewire 334 is no more than about 0.014 inch (0.356 mm) in majority of its length in the proximal segment and is tapered to no more than about 0.010 inch (0.254 mm) in the distal segment of the microguidewire e.g distal 30 cm.
- the distal segment of the microguidewire e.g. distal 30 cm comprises a core microguidewire 334 depicted in FIG.
- 9B-D that is no more than about 0.010 inch (0.254 mm) in thickness forming the thinner segment of the microguidewire 360 of FIGS. 9C-D , and comprises thicker segments proximal to the proximal stop 340 as well as distal to the distal stop 375 , where the core may be coated or covered by another layer or layers, e.g., a coil made up of a radio-opaque material or metal or alloy such as platinum as shown in FIG. 9C forming the shapeable tip of the microguidewire 395 , or a flexible hypotube 336 of FIG. 9D covering the core microguidewire 334 or a combination of both as shown in FIG. 9D .
- a coil made up of a radio-opaque material or metal or alloy such as platinum as shown in FIG. 9C forming the shapeable tip of the microguidewire 395
- a flexible hypotube 336 of FIG. 9D covering the core microguidewire 334 or a combination of both as shown in FIG. 9D
- the coating, or covering may provide more support as well as trackability that is need for catheterization of the small cerebral arterial blood vessels.
- the coated core microguidewire is no more than about 0.014 inch (0.356 mm) in thickness in the majority of its length.
- the various components of this distal segment of the microguidewire are illustrated in more detail in FIGS. 9B to 9D .
- the thinner segment of the microguidewire 360 is no more than about 0.010 inch (0.254 mm) to accommodate the filtering device in its non-expanded state and still maintain an overall low thickness profile of the distal embolic protection device. In this thinner segment of the microguidewire where the filtering device is mounted 360 , the components of the microguidewire are predominantly just the core microguidewire 334 as previously described.
- the distal end of the microguidewire 365 comprises several components that include a core microguidewire 334 as previously described, and a shapeable tip comprising a radio opaque material, metal or alloy, e.g., platinum, that is shapeable to provide some trackability and to retain a curved shape to avoid small vessel perforation.
- a shapeable tip of the distal end of the microguidewire 365 may also include a coating or covering layer, such as a flexible hypotube 336 , covering the core microguidewire 334 to give it more support and strength and is no more than about 0.014 inch (0.356 mm) in the majority of its length.
- the microguidewire has proximal 340 and distal 375 stops that allow the filtering device to be stationary in a small cerebral blood vessel despite rotatory and longitudinal motion of the microguidewire relative to the filtering device between the proximal and distal stops.
- the thickness of the stops is no more than about 0.017 inch (0.432 mm) and preferably from 0.014 to 0.017 inch (0.356-0.432 mm).
- variable thickness microguidewire may be made up of materials that are biocompatible or surface treated to produce biocompatibility. Suitable materials include e.g., stainless steel, platinum, titanium and its alloys including nickel-titanium, etc. Suitable materials also include a combination of metals and alloys such that the core of the microguidewire 334 forming the thinner segment 360 could be made from metals or alloys such as stainless steel or nickel-titanium etc.
- the distal end of the core microguidewire 334 is preferably covered by a coating of a radio-opaque material or metal or alloy, e.g., platinum.
- a radio-opaque material or metal or alloy e.g., platinum.
- the core microguidewire 334 may have a coating or covering layer, e.g., a flexible hypotube, and made of metals or alloys, e.g., nickel, titanium, platinum, tungsten etc.
- the coating or covering layer over the core microguidewire, or the flexible hypotube, or the core microguidewire itself comprise or are coated with radio-opaque materials, metals or alloys, including but not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above etc to enable visibility during neurovascular interventional procedures.
- FIG. 10 is an illustration of one of the embodiments of the distal embolic protection device comprising the filtering device and the microguidewire.
- the filtering device has a proximal 345 and distal 355 attachment points that are also the sliding or mobile components of the filtering device. These mobile attachment points have a capacity to allow the microguidewire to rotate 430 as well as move back and forth in the longitudinal direction 435 between the two stops in the microguidewire ( 340 , 375 ) while keeping the filtering device stationary in a small cerebral blood vessel and thereby decrease friction and trauma on the cerebral blood vessel walls.
- the filtering device of the distal embolic protection device of this invention may comprise a filter membrane and an expansion assembly capable of assuming an expanded configuration and a collapsed configuration.
- the expansion assembly comprises a plurality of struts ( 400 , 405 , 410 ) that connect the proximal attachment point 345 to the distal attachment point 355 .
- the filter membrane may be attached to the struts and the distal attachment point, and in the expanded configuration the filter membrane has a hemispherical shape covering the struts.
- the struts comprise a biocompatible material or materials that are surface treated for biocompatibility.
- the materials are preferably self-expanding. Suitable materials include but are not limited to stainless steel, titanium and its alloys, cobalt-chromium alloy, carbon fiber and its composites, and various biomedical polymers, e.g., polyurethane, polyethylene, polyester, polypropylene, poly tetra fluoro-ethylene, polyamides, polycarbonate or polyethylene-terephthalate. A shape memory or super-elastic material such as nickel-titanium alloy is also suitable.
- the number of struts will depend on the size of expansion needed for the diameter of the cerebral blood vessel.
- the distal embolic protection device will be suitable for use in cerebral blood vessels from vessel diameters of 1.5 mm to 4.5 mm.
- various portions of the distal embolic protection device including parts of the struts 400 to 410 , or parts of the filter membrane 415 may be radio-opaque.
- Radio-opaque materials are understood as materials that are visible on a fluoroscopy screen during neurovascular interventional procedures. This allows the operator to determine the location of the device during neurovascular interventions.
- Radio-opaque materials include, e.g., metals or alloys including but are not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above etc.
- the struts may comprise metals or alloys that are radio-opaque, e.g., platinum or the others listed above.
- the struts may comprise shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque but small portions of radio-opaque metals or alloys, e.g., tantalum, can be attached to non-radio-opaque struts by suturing the filter membrane to the struts with tantalum wires or other suitable radio-opaque material.
- shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque but small portions of radio-opaque metals or alloys, e.g., tantalum, can be attached to non-radio-opaque struts by suturing the filter membrane to the struts with tantalum wires or other suitable radio-opaque material.
- the filtering device also comprises a filter membrane 415 for collecting emboli or debris that might be released during the neurovascular intervention.
- the filter membrane may comprise a biomedical polymer, e.g., polyurethane (BioSpanTM made by Polymer Technology Group and ChronoflexTM made by CardioTech International), polyethylene (RexellTM made by Huntsman), polypropylene (InspireTM made by Dow), polyester (HytrilTM made by Dupont), poly tetra fluoro-ethylene (TeflonTM made by Dupont), polyamides (DurethanTM made by Bayer), polycarbonate (CorethaneTM made by Corvita Corp), or polyethylene-terephthalate (DacronTM made by Dupont).
- polyurethane BioSpanTM made by Polymer Technology Group and ChronoflexTM made by CardioTech International
- Polyethylene RexellTM made by Huntsman
- Polypropylene InspireTM made by Dow
- polyester HytrilTM made by Dupont
- TeflonTM poly
- the filter membrane may further comprise a radio-opaque material, e.g., particles of tantalum, particles of gold, other radio-opaque agents, e.g., barium sulfate, tungsten powder, bismuth subcarbonate, bismuth oxychloride, iodine containing agents such as iohexol (OmnipaqueTM made by Amersham Health).
- the filter membrane comprises pores 420 that are of the dimensions small enough to trap emboli or debris but large enough to allow the free passage of blood and its components such as blood cells preferably the pores are of 50 microns to 150 microns.
- the arrows 425 indicate the direction of blood flow within the blood vessel.
- the microguidewire is thinner between the two radio-opaque stops 340 and 375 and in this thin segment 360 , the microguidewire thickness is no more than about 0.010 inch (0.254 mm). This is to allow for the thickness of the filtering device comprising the struts such that in its non-expanded state the distal embolic protection device overall is no more than about 0.017 inch (0.432 mm).
- distal embolic protection device This is to enable the distal embolic protection device to be delivered through standard microcatheters that are commercially available (such as EchelonTM microcatheter, ev3 Inc; ExcelsiorTM microcatheter, Boston Scientific Corp; ProwlerTM microcatheter, Cordis Neurovascular etc) that have an internal diameter of around 0.017 inch (0.432 mm).
- standard microcatheters such as EchelonTM microcatheter, ev3 Inc; ExcelsiorTM microcatheter, Boston Scientific Corp; ProwlerTM microcatheter, Cordis Neurovascular etc
- FIG. 11 is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described in FIG. 10 .
- Some of the struts 400 and 405 are shown in an expanded configuration, wherein the filter membrane 415 is depicted with a hemispherical shape covering the struts.
- the microguidewire 360 passing through the center of the filtering device as well as the distal attachment point 355 of the filtering device are also shown.
- FIG. 12 is an illustration showing the distal embolic protection device described in FIG. 10 in an expanded configuration showing the radio-opaque components under fluoroscopy.
- the distal segment of the microguidewire 335 e.g. distal 30 cm is radio-opaque along with the proximal stop 340 and are made of radio-opaque metals or alloys, e.g., platinum, as mentioned in description of FIGS. 8A , 8 B and 10 .
- the microguidewire in the thinner segment 360 is not radio-opaque and is made up of a metal or alloy, e.g., nickel-titanium or stainless steel.
- the distal stop 375 as well as the distal end of the microguidewire 365 including the shapeable tip 395 are also made of a radio-opaque metal or alloy such as platinum as described in detail in FIGS. 8A , 8 B, and 10 .
- Portions of the struts 400 to 410 of the distal embolic protection device described in FIG. 10 are also made of a radio-opaque metal or alloy, e.g., platinum, or have a covering with a radio-opaque material, e.g., tantalum as described in FIG. 10 in detail. This enables the operator performing the neurovascular interventional procedure to clearly visualize the deployed distal embolic protection device as well as the position of the microguidewire.
- FIG. 13 is an illustration of another embodiment of a distal embolic protection device of this invention comprising a filtering device rotatably mounted on a variable-thickness microguidewire.
- the filtering device has proximal 345 and distal 355 attachment regions that are also the sliding or mobile components of the distal embolic protection device.
- These mobile attachment points have a capacity to allow the microguidewire to rotate 430 as well as move back and forth in the longitudinal direction 435 between the two stops in the microguidewire ( 340 , 375 ) while keeping the distal embolic protection device stationary in a small cerebral blood vessel and thereby help decrease friction and trauma on the cerebral blood vessel walls.
- the distal embolic protection device in this embodiment comprises an expansion assembly comprising a plurality of struts ( 400 , 405 , 410 ) that connect the proximal attachment point 345 to the distal attachment point 355 and are capable of assuming an expanded configuration and a collapsed configuration The expanded configuration of the plurality of struts and the filter membrane having a hemispherical shape is depicted.
- the distal embolic protection device further comprises two cylindrical coils 436 and 437 . Cylindrical coil 436 connects the proximal stop 340 to the proximal attachment point 345 of the filtering device. Cylindrical coil 437 connects the distal attachment point 355 of the filtering device to the distal stop 375 of the microguidewire.
- the cylindrical coils allow for rotatory 430 as well as longitudinal movement 435 of the filtering device relative to the microguidewire in the thinner segment of the microguidewire 360 .
- the cylindrical coils decrease the shear stress on the thinner segment of the microguidewire 360 when the distal embolic protection device is recovered with a microcatheter, balloon catheter or stent catheter.
- the coils provide added support to the thinner segment of the microguidewire 360 and reduce fracture or stretching of the microguidewire at the region of the proximal stop 340 or distal stop 375 .
- the cylindrical coils may be made of a biocompatible material, or a material that is surface treated to be biocompatible and may comprise radio-opaque metals or alloys, e.g., platinum, as described in detail in FIG. 10 .
- FIG. 14A is an illustration of another of the embodiments of the filtering device attached to the microguidewire.
- the filtering device comprises proximal 455 and distal 460 attachment points that are also the sliding or mobile components of the distal embolic protection device. These mobile attachment points have a capacity to allow the microguidewire to rotate 490 as well as move longitudinal direction 495 between the two proximal and distal stops of the microguidewire ( 340 , 375 ) while the filtering device remains stationary in the small cerebral blood vessel and thereby help to decrease friction and trauma on the cerebral blood vessel walls.
- the distal embolic protection device in this embodiment comprises a filter membrane attached to the distal end of the filtering device and an expansion assembly comprising a plurality of struts 465 , 470 , 475 that connect the proximal attachment point 455 of the filtering device to the distal attachment point of the filtering device 460 .
- the plurality of struts in the expanded configuration and the filter membrane having a helical or conical shape and covering the struts is also depicted.
- the struts preferably made of a biocompatible material or a material that is surface treated to be biocompatible and preferably made of a self-expanding material, are detailed in the embodiment described in FIG. 10 .
- Suitable materials include but are not limited to stainless steel, titanium and its alloys, cobalt-chromium alloy, carbon fiber and its composites, and various polymers.
- a shape memory or super-elastic material such as nickel-titanium alloy is also suitable.
- the number of struts will depend on the size of expansion needed for the diameter of the cerebral blood vessel.
- the distal embolic protection device will be suitable for use in cerebral blood vessels from vessel diameters 1.5 mm to 4.5 mm.
- various portions of the distal embolic protection devices of this invention including parts of the struts 505 and 510 , or parts of the filter membrane 480 may be radio-opaque.
- Radio-opaque materials are understood to be materials that are visible on a fluoroscopy screen during neurovascular interventional procedures. This allows the operator to determine the location of the device during neurovascular interventions.
- Radio-opaque materials include metals or alloys including but are not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above.
- the struts can be made of metals or alloys that are radio-opaque, e.g., platinum or the others listed above.
- the struts are made of shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque, and may further comprise small portions of radio-opaque metals or alloys such as tantalum, that can be attached to the non-radio-opaque struts by suturing the filter membrane to the struts with a radio-opaque material, e.g. tantalum wires etc.
- a radio-opaque material e.g. tantalum wires etc.
- the filtering device comprises a filter membrane 480 to capture emboli or debris that might be released during the neurovascular intervention.
- the filter membrane is preferably a biomedical polymer, e.g., polyurethane (BioSpanTM made by Polymer Technology Group and ChronoflexTM made by CardioTech International), polyethylene (RexellTM made by Huntsman), polypropylene (InspireTM made by Dow), polyester (HytrilTM made by Dupont), poly tetra fluoro-ethylene (TeflonTM made by Dupont), polyamides (DurethanTM made by Bayer), polycarbonate (CorethaneTM made by Corvita Corp), or polyethylene-terephthalate (DacronTM made by Dupont).
- polyurethane BioSpanTM made by Polymer Technology Group and ChronoflexTM made by CardioTech International
- Polyethylene RexellTM made by Huntsman
- Polypropylene InspireTM made by Dow
- polyester HytrilTM made by Dupont
- TeflonTM poly
- the filter membrane may further comprise a radio-opaque material, e.g., particles of tantalum, particles of gold, other radio-opaque agents such as barium sulfate, tungsten powder, bismuth subcarbonate, bismuth oxychloride, iodine containing agents such as OmnipaqueTM.
- the filter has pores 485 that are small enough to trap emboli or debris but large enough to allow the free passage of blood and its components such as blood cells, preferably the pores are 50 microns to 150 microns in diameter.
- the arrows 500 indicate the direction of blood flow within the cerebral blood vessel.
- the microguidewire is thinner between the two radio-opaque stops 340 and 375 and in this thinner segment 360 , the microguidewire thickness is no more than about 0.010 inch (0.254 mm). This is to accommodate the filtering device such that in its non-expanded configuration the thickness of the filtering device is less than or equal to 0.017 inch (0.432 mm). This is to enable the distal embolic protection device to be delivered through standard microcatheters that are commercially available (such as EchelonTM microcatheter, ev3 Inc; ExcelsiorTM microcatheter, Boston Scientific Corp; ProwlerTM microcatheter, Cordis Neurovascular etc) that have an internal diameter of about 0.017 inch (0.432 mm).
- FIG. 14B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described in FIG. 14A .
- the struts 465 to 475 are depicted in an expanded configuration, providing the filtering device with a helical or conical shape.
- the filter membrane 480 is depicted as covering the struts 465 , 470 , 475 .
- the microguidewire 360 passing through the center of the filtering device as well as the distal attachment point 460 of the filtering device are shown.
- FIG. 15A is an illustration of another embodiment of the distal embolic protection device.
- the filtering device has proximal 535 and distal 530 attachment points that are also the sliding or mobile components of the filtering device. These mobile attachment points have a capacity to allow the microguidewire to rotate 565 as well as move back and forth in the longitudinal direction 570 relative to the filtering device between the two stops in the microguidewire ( 340 , 375 ) while keeping the filtering device stationary in a small cerebral blood vessel and thereby decrease friction and trauma on the cerebral blood vessel walls.
- the filtering device in this embodiment comprises a filter membrane 555 and a ring 525 . The filter membrane is attached to the ring and the ring is connected to the proximal attachment point 535 .
- the ring in turn comprises a plurality of struts 540 , 545 , 550 that connect the ring 525 to the distal attachment point 530 .
- the ring and if present the plurality of struts when expanded can provide the filtering device with a conical shape.
- the ring, and if present the plurality of struts are made of biocompatible materials or materials that are surface treated such that they are biocompatible.
- the materials are preferably self-expanding as described in FIG. 10 .
- Suitable materials include but are not limited to stainless steel, titanium and its alloys, cobalt-chromium alloy, carbon fiber and its composites, and various polymers.
- a shape memory or super-elastic material such as nickel-titanium alloy is also suitable.
- the number of struts will depend on the size of expansion needed for the diameter of the cerebral blood vessel to be treated.
- the distal embolic protection devices of this invention are suitable for use in cerebral blood vessels from vessel diameters 1.5 mm to 4.5 mm.
- various portions of the distal embolic protection device including the ring 525 , or parts of the filter membrane 555 may further comprise a radio-opaque material.
- Radio-opaque materials are understood as materials that are visible on a fluoroscopy screen during neurovascular interventional procedures. This allows the operator to determine the location of the device during neurovascular interventions.
- Radio-opaque materials can include metals or alloys, including but not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above etc.
- the struts can be made up of metals or alloys that are radio-opaque such as platinum or the others listed above.
- the struts may be made of shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque, but may be made radio-opaque by attaching small portions of radio-opaque metals or alloys, e.g., tantalum, to the non-radio-opaque struts by suturing the filter membrane to the struts with a radio-opaque material, e.g., tantalum wires etc.
- shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque, but may be made radio-opaque by attaching small portions of radio-opaque metals or alloys, e.g., tantalum, to the non-radio-opaque struts by suturing the filter membrane to the struts with a radio-opaque material, e.g., tantalum wires etc.
- the filtering device comprises a filter membrane 555 that extends from the ring 525 to the distal attachment point 530 and acts as a filter for emboli or debris that might be released during the neurovascular intervention.
- the filter membrane may cover the struts.
- Materials for this filter include but are not limited to biomedical polymers such as, e.g., polyurethane (BioSpanTM made by Polymer Technology Group and ChronoflexTM made by CardioTech International, polyethylene (RexellTM made by Huntsman), polypropylene (InspireTM made by Dow), polyester (HytrilTM made by Dupont), poly tetra fluoro-ethylene (TeflonTM made by Dupont), polyamides (DurethanTM made by Bayer), polycarbonate (CorethaneTM made by Corvita Corp), or polyethylene-terephthalate (DacronTM made by Dupont).
- biomedical polymers such as, e.g., polyurethane (BioSpanTM made by Polymer Technology Group and Chr
- the filter has pores 560 that are small enough to trap emboli or debris but large enough to allow the free passage of blood and its components such as blood cells. Preferably the pores are 50 microns to 150 microns.
- the arrows 575 indicate the direction of blood flow with the cerebral blood vessel.
- the filter membrane may further comprise radio-opaque materials, e.g., as particles of tantalum, particles of gold, other radio-opaque agents, e.g., barium sulfate, tungsten powder, bismuth subcarbonate, bismuth oxychloride, iodine containing agents such as OmnipaqueTM.
- the microguidewire is thinner between the two radio-opaque stops 340 and 375 and in this thinner segment 360 , the microguidewire thickness is no more than about 0.010 inch (0.254 mm). This is to allow for the thickness of the distal embolic protection device, the ring and the struts if present such that in the non-expanded state the ring of the distal embolic protection device is no more than about 0.017 inch (0.432 mm).
- distal embolic protection device This is to enable the distal embolic protection device to be delivered through standard microcatheters that are commercially available (such as EchelonTM microcatheter, ev3 Inc; ExcelsiorTM microcatheter, Boston Scientific Corp; ProwlerTM microcatheter, Cordis Neurovascular etc) that have an internal diameter of about 0.017 inch (0.432 mm).
- standard microcatheters such as EchelonTM microcatheter, ev3 Inc; ExcelsiorTM microcatheter, Boston Scientific Corp; ProwlerTM microcatheter, Cordis Neurovascular etc
- FIG. 15B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described in FIG. 15A .
- the radio-opaque ring is shown 525 and is attached to a filter membrane 555 connecting the ring to the distal attachment point 530 .
- the filter membrane has micro-pores 560 .
- the microguidewire 360 passing through the side of the filtering device as well as the proximal 535 and distal attachment points 530 of the filtering device are shown.
- FIG. 16 is a schematic diagram illustrating a significant blockage or stenosis 585 in the right middle cerebral artery 105 that is causing mini-strokes and is refractory to medical therapy.
- a guide catheter (6 French or larger) 580 has been advanced into the right internal carotid artery 30 so that intracranial balloon angioplasty and stenting can be performed.
- FIG. 17 is a schematic diagram illustrating that through the guide catheter in the right internal carotid artery, a microcatheter 590 is being advanced in the right internal carotid artery into the right middle cerebral artery over a microwire 600 .
- the microwire is carefully advanced across the blockage in the right middle cerebral artery 585 .
- the microcatheter is then advanced over the microwire.
- FIG. 18 is a schematic diagram illustrating that the microcatheter 590 has been carefully advanced across the blockage in the right middle cerebral artery 585 over a microwire.
- the microwire has been removed once the microcatheter is distal to the blockage 585 in the right middle cerebral artery.
- a distal embolic protection device Prior to exchanging the microcatheter for a balloon catheter, a distal embolic protection device is decided to be advanced to the right middle cerebral artery through the microcatheter.
- FIG. 19 is a schematic diagram illustrating the introducer sheath 305 with the non-expanded distal embolic protection device 310 comprising microguidewire 290 are being advanced through the microcatheter 590 .
- the hemostatic valve 295 at the proximal end of the introducer sheath is released so that the microguidewire 290 can be advanced.
- the introducer sheath 305 can be removed.
- the guide catheter 580 is connected to a rotating hemostatic valve 595 to prevent back-bleeding.
- the microcatheter 590 passes through the rotating hemostatic valve 595 and then into the guide catheter 580 .
- FIG. 20 is a schematic diagram illustrating the distal embolic protection device 350 in the non-expanded state in the appropriate location distal to the blockage 585 in the right middle cerebral artery.
- the microcatheter 590 With the microguidewire 365 in position and fixed, the microcatheter 590 is being withdrawn to deploy the filtering device.
- the tip of the microguidewire 395 is shaped to avoid perforating a small vessel.
- the distal stop 375 in the microguidewire acts as the radio-opaque marker.
- FIG. 21 is a schematic diagram illustrating the distal embolic protection device fully deployed in the right middle cerebral artery distal to the blockage 585 .
- the radio-opaque distal part of the microguidewire 365 along with the shapeable tip 395 are noted.
- the radio-opaque stops of the microguidewire 340 and 375 are noted.
- the filtering device with the plurality of struts 405 and 410 between the two attachment points 345 and 355 are noted.
- the filter membrane 415 is noted.
- FIG. 22 is a schematic diagram illustrating the filtering device is in place distal to the blockage 585 in the right middle cerebral artery.
- the microcatheter With the microguidewire in position, the microcatheter is exchanged for a balloon catheter 605 .
- the mobile attachment points 345 and 355 of the filtering device allow for the filtering device to be stationary even if there is minimal movement of the microguidewire 335 during the microcatheter exchange.
- intracranial balloon angioplasty is performed.
- emboli or debris are released 615 and are collected in the distal embolic protection device by the filter 415 .
- FIG. 23 is a schematic diagram illustrating that after intracranial angioplasty, the balloon 610 shown in FIG. 22 is deflated and the balloon catheter 605 is exchanged for an intracranial stent catheter 620 over the microguidewire.
- the stent When the stent is in position across the area of blockage 630 in the right middle cerebral artery where balloon angioplasty was performed, the stent is deployed.
- small emboli or debris are released 615 and are collected in the filter 415 of the distal embolic protection device.
- the distal embolic protection device can be retrieved using the stent catheter 620 by advancing it over the microguidewire till the radio-opaque markers in struts of the distal embolic protection device suggest that the filter has closed so that the device can be safely removed.
- FIG. 24 is a schematic diagram illustrating a standard microcatheter, which can be alternatively used to retrieve the distal embolic protection device.
- the stent catheter 620 shown in FIG. 23 is exchanged for a standard catheter 590 over the microguidewire 335 .
- the standard microcatheter has a proximal 640 and distal end 645 .
- Standard microcatheters that are commercially available (such as EchelonTM microcatheter, ev3 Inc; ExcelsiorTM microcatheter, Boston Scientific Corp; ProwlerTM microcatheter, Cordis Neurovascular etc) can be used and their inner lumen diameter range from 0.017 to 0.021 inch (0.432 mm to 0.533 mm) and are usually 135 to 175 cm in length.
- FIG. 25 is a schematic diagram illustrating the tip of the standard microcatheter 645 being advanced over the microguidewire such that the filtering device 350 closes to the collapsed configuration to prevent spillage of the emboli or debris collected during the procedure.
- the stent is noted to be in good position 625 across the angioplastied area 630 .
- FIG. 26 is a schematic diagram illustrating the filtering device 350 in the closed non-expanded state being carefully withdrawn into the guide catheter 580 .
- the microcatheter tip 645 is closely approximated to the struts of the filtering device to prevent spillage of the contents of the distal embolic protection device namely emboli or debris.
- the stent is noted to be in good position 625 across the angioplastied area 630 .
- FIG. 27 is a schematic diagram illustrating another use for this distal embolic protection device.
- This figure illustrates a thrombus or blood clot 650 in the right middle cerebral artery and is occluding this right middle cerebral artery and causing an acute ischemic stroke.
- the patient presents after 3 hours from symptom onset and is a candidate for immediate neurovascular interventional therapy with intra-arterial thrombolytic infusion.
- a guide catheter 580 (6 French or greater) is advanced into the right internal carotid artery.
- FIG. 28 is a schematic diagram illustrating a standard microcatheter 590 being advanced across the thrombus or blood clot 650 in the right middle cerebral artery over a microwire 600 . Once the microcatheter is across the thrombus or blood clot, the microwire will be removed and a microcatheter angiogram may be performed to identify if the cerebral blood vessels distal to the thrombus or blood clot are patent.
- FIG. 29 is a schematic diagram illustrating a distal embolic protection device is advanced through the microcatheter 590 into a position distal to the thrombus or blood clot 650 and then the microcatheter is withdrawn to the proximal part of the right middle cerebral artery to deploy the distal embolic protection device.
- the radio-opaque stops 340 and 375 in the microguidewire, as well as, the radio-opaque attachment points 455 and 460 of the distal embolic protection device are well visualized. Also the distal radio-opaque microguidewire segment 365 and the shapeable tip 395 are well visualized.
- Intra-arterial thrombolytic infusion is initiated through the microcatheter with the microguidewire in position 335 .
- the thrombus or blood clot is broken down 655 into smaller emboli or debris 660 , which are collected in the filter membrane 480 of the distal protection device.
- the struts 470 of the distal embolic protection device are in the expanded position to maintain the shape of the filter membrane.
- FIG. 30 is a schematic diagram illustrating after intra-arterial thrombolysis, the microcatheter 590 is advanced over the microguidewire such that the filtering device 350 closes to the collapsed configuration to prevent spillage of the emboli or debris collected during the procedure.
- the filtering device 350 in the closed non-expanded state is then carefully withdrawn into the guide catheter 580 . All through the process, the microcatheter tip 645 is closely approximated to the struts of the distal embolic protection device to prevent spillage of the contents of the distal embolic protection device namely emboli or debris.
Abstract
Description
- The present application is a continuation of U.S. patent application Ser. No. 11/859,272, filed Sep. 21, 2007 and issued as U.S. Pat. No. 9,034,007 on May 19, 2015. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 C.F.R. §1.57.
- This invention is related generally to the field of intravascular medical devices. Particularly a distal embolic protection device as well as methods for use of the device during neurovascular interventional procedures in the cerebral arterial blood vessels.
- Stroke is the leading cause of long term disability in the United States and the second leading cause of death worldwide with over 4.4 million deaths in a year (1999).1 There are over 700,000 new strokes every year in the United States.2 Around 85% of all strokes are acute ischemic strokes caused from a blockage in a blood vessel or a blood clot occluding a blood vessel.2 In 1996, the FDA approved a thrombolytic drug to dissolve blood clots called recombinant tissue plasminogen activator (r-tpa).3 Despite practice guidelines from multiple national organizations stating the intravenous r-tpa is the standard of care for patients with acute ischemic stroke within 3 hours from symptom onset,3 only 3-4% of patients with acute ischemic stroke received this drug in the United States.4 Unlike intravenous r-tpa, Intra-arterial infusion of thrombolytic agents can be used for up to 6 hours from acute ischemic stroke symptom onset and could benefit more people.5 Currently, intra-arterial infusion of thrombolytic agents are administered to a blood clot and the blood clot breaks up into smaller blood clots and travel downstream and potentially close up smaller cerebral blood vessels. With advances in regional stroke networks, there are more and more stroke patients who are getting access to intra-arterial thrombolysis and therapies, and are as high as 21.6%.4 However, there is no currently available distal embolic protection device that is dedicated to the cerebral blood vessels.
- More than 8% of all acute ischemic strokes are from blockages in the cervical or neck carotid artery.2 Studies have shown that performing percutaneous balloon angioplasty and stenting on these blockages result in emboli or debris being dislodged downstream and could cause further strokes and therefore there have been large clinical trials of angioplasty and stenting of the carotid artery in the neck with distal embolic protection devices being used.6 In addition to blockages in the neck region of the carotid artery, more than 8% of all acute ischemic strokes are due to blockages in the cerebral arterial blood vessels called intracranial stenosis.2 Recently there has been a new device approved for intracranial angioplasty and stenting.7 Although the risks of small emboli or debris being dislodged during intracranial angioplasty and stenting is similar to the cervical carotid artery and the rest of the body, there are no distal embolic protection devices in the market dedicated for cerebral arterial blood vessels. In addition, the distal embolic protection devices currently available for the cervical carotid artery are too bulky for use in the tortuous and fragile cerebral arterial blood vessels.
- Embolic protection devices have been developed for the cervical carotid artery prior to carotid angioplasty and stenting.6 However, these devices do not have a small profile for use in the cerebral arterial blood vessels and will not be able to track and traverse the tortuous cerebral arterial blood vessels.
- Barbut in U.S. Pat. No. 6,165,199 has described embolic protection devices that can be used for the cerebral arterial blood vessels. This is a proximal embolic protection device wherein the embolic protection device is before the clot or blockage comprising of a proximal balloon occlusion catheter to create flow arrest and an aspiration device to suction out the emboli or debris during the interventional procedure in the cervical and cerebral blood vessels. The drawbacks of a proximal protection device are that the flow arrest performed to decrease emboli or debris from traveling downstream can be detrimental in itself, since creating a flow arrest in an already ischemic blood vessel during the long neurovascular interventional procedures would in itself worsen the cerebral ischemia and worsen the strokes. Bose et al in U.S. Pat. No. 6,669,721 describe thin-film distal embolic protection devices that can be potentially used in the cerebral blood vessels. The device has one or two rings and a thin-film filter that is attached to the guidewire. The drawbacks of this device is that during neurovascular interventional procedures, there is constant exchange of microcatheters, balloon catheters, and stent catheters over the guidewire or microguidewire, and a distal embolic protection device that is rigidly fixed to the guidewire or microguidewire would cause trauma to the cerebral arterial blood vessel wall as there will not be any mobility of the wire independent of the distal embolic protection device. Hopkins et al in U.S. Pat. No. 6,544,279 B1 describe distal embolic protection devices that do have mobility over a guidewire or microguidewire, however these guidewires or microguidewires are of uniform thickness and the mobile attachment point in these devices extend through the entire length of the device. Current microguidewires used in neurovascular interventional procedures to perform intracranial angioplasty and stenting among other procedures use microguidewires in the thickness of 0.014 inch (0.356 mm).7 Current microcatheters used for intracranial cerebral blood vessel catheterization for stroke as well as during intracranial angioplasty and stenting have an inner diameter of about 0.017 inch (0.432 mm). Having a distal embolic protection device mounted on a uniform thickness microguidewire of a thickness of 0.014 inch (0.356 mm) will not permit the distal embolic protection device in the collapsed form to have a thin enough or small enough profile to be compatible with existing microcatheters that are 0.017 inch (0.432 mm) in inner diameter. Having a distal embolic protection device mounted on a uniform thickness microguidewire with a mobile attachment point that extends through the entire length of the device will increase the overall thickness of the device in the collapsed configuration thereby limiting the trackability of the device and inhibiting access to the tortuous and narrow cerebral arterial blood vessels.
- The present invention provides a distal embolic protection device that can be used for neurovascular interventional procedures including, but not limited to, intra-arterial thrombolytic or clot dissolving drug infusion for acute ischemic stroke, as well as percutaneous transluminal intracranial balloon angioplasty and stenting procedures for patients at risk for stroke so that the small emboli or debris that are dislodged during these procedures can be retrieved safely. The distal embolic protection device of this invention has a thin and small profile such that they are compatible with existing standard microcatheters. The distal embolic protection device of this invention is not attached to a balloon or stent. The present invention also addresses the limitations of all the prior art on embolic protection devices discussed above as well as those that have been referenced.
- An object of this invention is to have a distal embolic protection device that is dedicated to the cerebral arterial blood vessels and is suitable for use in cerebral arterial blood vessels of 1.5 mm to 4.5 mm in diameter. The definition of cerebral arterial blood vessels is described in the detailed description of
FIGS. 1 , 2 and 3. - Another object of this invention is to have an embolic protection device that does not have to cause flow arrest to provide embolic protection. Devices that cause flow arrest have a risk of worsening a stroke. Therefore the embolic protection device of this invention is distal rather than proximal to the blockage or blood clot and not proximal to the blockage or blood clot.
- Another object of this invention is to have a distal embolic protection device that can pass through the tortuous cerebral arterial blood vessels with no or little trauma to the vessels. Current embolic protection devices are transported or moved through catheters using a small stearable microwire. Due to the bulky nature of current embolic protection devices, it is very difficult to navigate through even in straight blood vessels leave alone tortuous blood vessels.
- Another object of this invention is to have a distal embolic protection device comprising a collapsible filtering device that has a small thin profile so that in the collapsed configuration of the filtering device, the thickness of the distal embolic protection device is no more than about 0.017 inch (0.432 mm), preferably no more than about 0.014 inch (0.356 mm), and can be delivered and retrieved via a standard microcatheter (inner diameter of 0.017 inch, 0.432 mm), a balloon catheter or stent catheter that are used in neurovascular interventional procedures. The filtering device is not attached to a balloon or stent.
- Another object of this invention is a distal embolic protection device comprising a variable thickness microguidewire and a collapsible filtering device, wherein the filtering device is rotatably mounted on the distal segment of the variable thickness microguidewire. The variable thickness microguidewire comprises a thinner segment bordered on both ends by thicker segments. The thinner segment is no more than about 0.010 inches in thickness and preferably about 0.008 to 0.010 inch (0.203 to 0.254 mm). The thicker segments, which make up the majority of the microguidewire, are thicker than the thinner segment and preferably no more than 0.017 inch (0.432 mm) in thickness, more preferably no more than about 0.014 inch (0.356 mm). The variable thickness microguidewire may comprise a core microguidewire that extends through the entire length, or a portion of, of the microguidewire and a coating or covering or flexible hypotube or a combination thereof over the core microguidewire. The filtering device is mounted on the thinner segment, which is in the distal segment of the microguidewire to maintain a small thin profile so that trackability is maintained as well as compatibility with existing microcatheters, balloon catheters and stent catheters that are used in neurovascular interventional procedures. Preferably the small thin profile is no more than about 0.017 inch (0.432 mm) and more preferably no more than about 0.014 inch (0.356 mm).
- Another object of this invention is a distal embolic protection device comprising a variable thickness microguidewire and a filtering device, wherein the microguidewire and filtering device have rotational and longitudinal movement relative to and independently of each other, such that the filtering device can remain stable within the blood vessel while there is motion on the microguidewire both in the rotational as well as longitudinal directions relative to the filtering device so that there is no, or very limited, trauma to the fragile cerebral arterial blood vessels.
- The filtering device of the distal embolic protection device of this invention may comprise mobile attachment points on its proximal and distal ends wherein the mobile attachment points attach the filtering device to the microguidewire. The mobile attachment points are of such a size that that the thickness of the filtering device in the collapsed configuration is smaller than a cerebral arterial blood vessel and can pass through standard microcatheters that are used in neurovascular interventional procedures. Preferably the attachment points in conjunction with the filtering device in the collapsed configuration are no more than about 0.017 in (0.432 mm), and more preferably not more than about 0.014 inch (0.356 mm) in thickness. Preferably the attachment points are short and abut, but do not cover, the thicker segments of the microguidewire.
- In an embodiment of this invention, the distal embolic protection device comprises a filtering device rotatably mounted on the thinner segment of the microguidewire, and further comprises cylindrical coils that wind around the thinner segment of the microguidewire and connect the proximal and distal ends of the filtering device to the proximal and distal stops of the thicker segments of the microguidewire. The attached cylindrical coils decrease the shear stress on the thinner segment of the microguidewire during the retrieval of the distal embolic protection device.
- Another object of this invention the distal embolic protection device comprises a radio-opaque portion that enables the device to be visualized during fluoroscopic neurovascular interventional procedures. For example, the thicker segments of the microguidewire, or the distal end of the microguidewire, or the filtering device itself may comprise radio-opaque sections so that the operator during a medical procedure can distinguish the filtering device and its position relative to the thicker and thinner segments of the microguidewire.
- The distal embolic protection devices of this invention are dedicated to use in cerebral arterial blood vessels and their use in the treatment of existing stroke patients and patients that are at risk for strokes. The methods of this invention include e.g., crossing a vascular blockage or blood clot with a standard microcatheter and microwire. Then removing the microwire and once the microwire is removed, the distal embolic protection device is advanced via the microcatheter to the desired location. As the distal embolic protection device is not involved in navigation, it is able to pass the tortuous curves of the cerebral blood vessels due to the novel delivery system. The microguidewire is also designed to be compatible with existing microcatheters, balloon catheters and stent catheters used in neurovascular interventions. In addition, the stops in the distal part of the microguidewire and the mobile attachment points on the filtering device allow for mobility of the microguidewire both in the rotatory and longitudinal directions relative to the filtering device, wherein the filtering device is stable in the cerebral blood vessel thereby minimizing vessel trauma or dissections. The variable thickness of the distal part of the microguidewire also allows for the smaller overall profile of the device and improves its compatibility with existing microcatheters, balloon catheters, and stent catheters. The small profile also allows for easy retrieval of the distal embolic protection device of this invention using existing microcatheters, balloon catheters or stent catheters making the procedure shorter and safer.
- The methods of this invention for collecting thrombo-embolic material, debris or clots released during percutaneous neurovascular interventional procedures specifically performed in the cerebral arterial blood vessels, comprises inserting the distal embolic protection device of this invention into a cerebral arterial blood vessel having an area of stenosis or a clot, deploying the filtering device distal to the area of blockage or clot and allowing the filtering device to expand to fill the diameter of the cerebral arterial blood vessel. The methods of this invention may further comprise advancing a standard microcatheter over a standard microwire across the area of stenosis or clot, positioning the microcatheter distal to the stenosis or clot, withdrawing the microwire, and advancing the distal embolic protection device through the standard microcatheter. The thickness of the thicker segments of the variable thickness microguidewire is no more than about 0.017 inch (0.432 mm) and preferably no more than about 0.014 inch (0.356 mm) such that it is compatible for use with standard microcatheters, which have an inner lumen diameter of about 0.017 inch (0.432 mm). In addition, the methods of this invention may further comprise withdrawing the microcatheter, while keeping the microguidewire in position distal to the stenosis or clot, unsheathing the distal embolic protection device and expanding the filtering device to the inside size of the cerebral arterial blood vessel, ranging from 1.5 mm to 4.5 mm, and wherein the expanded shape of the filter membrane is a hemispherical, helical or conical shape and spans the cerebral arterial blood vessel. The method may also comprise maintaining the microguidewire in position, exchanging the standard microcatheter for (1) a balloon catheter to perform balloon angioplasty of the cerebral arterial blood vessels, or (2) a stent catheter to perform stenting of the cerebral arterial blood vessels, and collecting any debris or clots that are dislodged during the balloon angioplasty and or stenting in the cerebral arterial blood vessels in the filter membrane. The methods of this invention also comprise maintaining the microguidewire in position and administering clot dissolving drugs or thrombolytics to a patient in need thereof through a standard microcatheter, such that any debris or clots that are dislodged will be collected by the filter membrane. The methods of this invention may comprise additional steps, e.g., recovering the distal embolic protection device by advancing a standard microcatheter, balloon catheter, or stent catheter over the variable thickness microguidewire, and withdrawing the distal embolic protection device and the standard microcatheter, balloon catheter or stent catheter.
- Various embodiments of the present invention are shown in the figures and described in detail below.
-
FIG. 1 is a schematic diagram illustrating the origin of the great vessels from the heart. -
FIG. 2 is a schematic diagram illustrating the cervical and cerebral course of the internal carotid arteries and their branches. -
FIG. 3 is a schematic diagram illustrating the cervical and cerebral course of the vertebral arteries and their branches. -
FIG. 4 is a schematic diagram illustrating the Circle of Willis and the main collateral blood vessel pathways in the brain. -
FIG. 5 illustrates the introducer system for delivery of the distal embolic protection device into the microcatheter. -
FIG. 6 illustrates the introducer sheath and its components. -
FIG. 7A illustrates a magnified cross sectional view of an introducer sheath with the distal embolic protection device comprising the filtering device and variable thickness microguidewire.FIG. 7B illustrates a magnified view of the variable-thickness microguidewire with the filtering device mounted on it and shown in a collapsed configuration within the microcatheter. -
FIGS. 8A and 8B illustrate the microguidewires in twolengths 300 cm and 190 cm respectively. -
FIG. 9A is an illustration of the distal segment of the microguidewire (distal 30 cm).FIGS. 9B , 9C and 9D are magnified views of embodiments of the variable thickness microguidewire with different components of the distal segment of the microguidewire illustrated (distal 30 cm). -
FIG. 10 is an illustration of one of the embodiments of the distal embolic protection device. -
FIG. 11 is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described inFIG. 10 . -
FIG. 12 illustrates one of the embodiments of a distal embolic protection device in the expanded configuration showing the radio-opaque components under fluoroscopy. -
FIG. 13 illustrates another embodiment of a distal embolic protection device over the variable thickness microguidewire. -
FIG. 14A is an illustration of another embodiment of the distal embolic protection device. -
FIG. 14B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described inFIG. 14A . -
FIG. 15A is an illustration of another embodiment of the distal embolic protection device. -
FIG. 15B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described inFIG. 15A . -
FIG. 16 is a schematic diagram illustrating a significant blockage orstenosis 585 in the right middlecerebral artery 105. -
FIG. 17 is a schematic diagram illustrating a microcatheter being advanced into the right middle cerebral artery over a microwire. -
FIG. 18 is a schematic diagram illustrating the microcatheter has been carefully advanced across the blockage in the right middle cerebral artery over a microwire. -
FIG. 19 is a schematic diagram illustrating the introducer sheath with the non-expanded distal embolic protection device and microguidewire are being advanced through the microcatheter. -
FIG. 20 is a schematic diagram illustrating the distal embolic protection device in the appropriate location distal to the blockage and the microcatheter being withdrawn to deploy the device. -
FIG. 21 is a schematic diagram illustrating the distal embolic protection device fully deployed. -
FIG. 22 is a schematic diagram illustrating intracranial angioplasty being performed using the distal embolic protection device. -
FIG. 23 is a schematic diagram illustrating intracranial stenting being performed using the distal embolic protection device. -
FIG. 24 is a schematic diagram of a standard microcatheter used to recover the distal embolic protection device. -
FIG. 25 is a schematic diagram illustrating the stent catheter or the tip of the standard microcatheter being advanced over the microguidewire to retrieve the distal embolic protection device. -
FIG. 26 is a schematic diagram illustrating the distal embolic protection device being safely retrieved by either the stent catheter or a standard microcatheter. -
FIG. 27 is a schematic diagram illustrating another use for this distal embolic protection device namely during intra-arterial thrombolysis for thrombus or blood clot causing acute ischemic stroke. -
FIG. 28 is a schematic diagram illustrating a standard microcatheter being advanced across the thrombus or blood clot in the right middle cerebral artery over a microwire. -
FIG. 29 is a schematic diagram illustrating a distal embolic protection device being deployed distal to the thrombus or blood clot causing the stroke and then the microcatheter is withdrawn back and intra-arterial thrombolysis is initiated. -
FIG. 30 is a schematic diagram illustrating the retrieval of the distal embolic protection device with the standard microcatheter. -
FIG. 1 is a schematic diagram that illustrates the heart, the aorta and the supra-aortic vessels. Theleft ventricle 5 is one of the chambers of the heart and pumps oxygenated blood to the rest of the body through theaorta 10. Theinnominate artery 15 is one of the great vessels originating from theaorta 10 and divides into two branches namely the rightsubclavian artery 20 and the right commoncarotid artery 25. The right commoncarotid artery 25 gives off the right internalcarotid artery 30 that continues intracranially to supply the anterior circulation or the front of the brain (seeFIG. 2 for further details), and the right externalcarotid artery 35 which continues to supply the scalp, face and neck. The rightsubclavian artery 20 gives off several branches including the rightvertebral artery 40 which continues intracranially to supply the posterior circulation or the back of the brain (seeFIG. 3 for further details). The next great vessel originating from theaorta 10 is the left commoncarotid artery 45. The left commoncarotid artery 45 divides into the left internalcarotid artery 50, which continues intracranially to supply the anterior circulation or the front of the brain (seeFIG. 2 for further details), and the left externalcarotid artery 55, which continues to supply the scalp, face and neck. This portion of theaorta 10 from which the left common carotid artery arises is also known as theaortic arch 60. The leftsubclavian artery 65 arises from theaortic arch 60 and gives off several branches including the leftvertebral artery 70 which continues intracranially to supply the posterior circulation or the back of the brain (seeFIG. 3 for further details). Subsequent to the origin of the leftsubclavian artery 65, the aortic arch curves inferiorly or downwards and is known as the descendingaorta 75 which continues to supply the abdomen, spine and lower extremities. -
FIG. 2 is a schematic diagram illustrating the cervical and intracranial course of the internal carotid arteries. The right commoncarotid artery 25 divides into the right externalcarotid artery 35 and the right cervical internalcarotid artery 30 in the neck. The right internal carotid artery in the cervical orneck portion 30 enters the base of skull and continues as the petrous portion of the right internalcarotid artery 80. The petrous portion of the right internalcarotid artery 80 then continues as the tortuous cavernous portion of the right internalcarotid artery 85. The right internal carotid artery then pierces the dura or covering layering of the brain to form the supraclinoid portion of the right internalcarotid artery 90 and gives off the rightposterior communicating artery 95 which helps form the circle of Willis or the collateral pathway to other blood vessels in the brain (seeFIG. 4 for further details). The supraclinoid portion of the right internalcarotid artery 90 then bifurcates 100 into the right middlecerebral artery 105 as well as the right anteriorcerebral artery 120 at the right internalcarotid artery bifurcation 100. The right middle cerebral artery divides into several branches and the main ones being the right middle cerebral arterysuperior division 110 and the right middle cerebral arteryinferior division 115. The A1 segment of the right anteriorcerebral artery 120 further continues as the A2 segment of the right anteriorcerebral artery 125 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicatingartery 130 that communicates with the blood vessels from the left side of the brain to also form the circle of Willis. - The left common
carotid artery 45 divides into the left externalcarotid artery 55 and the left cervical internalcarotid artery 50 in the neck. The left internal carotid artery in the cervical orneck portion 50 enters the base of skull and continues as the petrous portion of the left internalcarotid artery 180. The petrous portion of the left internalcarotid artery 180 then continues as the tortuous cavernous portion of the left internalcarotid artery 175. The left internal carotid artery then pierces the dura or covering layering of the brain to form the supraclinoid portion of the left internalcarotid artery 165 and gives off the leftposterior communicating artery 170 which helps form the circle of Willis or the collateral pathway to other blood vessels in the brain. The supraclinoid portion of the left internalcarotid artery 165 then bifurcates 145 into the left middlecerebral artery 150 as well as the left anteriorcerebral artery 140 at the left internalcarotid artery bifurcation 145. The left middle cerebral artery divides into several branches and the main ones being the left middle cerebral arterysuperior division 155 and the left middle cerebral arteryinferior division 160. The A1 segment of the left anteriorcerebral artery 140 further continues as the A2 segment of the left anteriorcerebral artery 135 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicatingartery 130 that communicates with the blood vessels from the right side of the brain to also form the circle of Willis. - In this invention, the internal carotid arteries from the petrous, cavernous and supraclinoid portions and their branches, along with the middle cerebral and anterior cerebral arteries and their branches are considered as cerebral arterial blood vessels (80 to 180).
-
FIG. 3 is a schematic diagram illustrating the course of the bilateral vertebral arteries and their branches. The rightvertebral artery 40 is a branch of the rightsubclavian artery 20. The first portion of the right vertebral artery in the cervical or neck portion is called the V1 segment of the rightvertebral artery 40. The right vertebral artery continues in the neck as the V2 segment of the rightvertebral artery 185 and travels close to the base of brain. It makes a tortuous curve and is called the V3 segment of the rightvertebral artery 190 and finally pierces the dura or outer covering layer of the brain and forms the V4 segment of the rightvertebral artery 195. The V4 segment of the rightvertebral artery 195 gives off an important branch to the right cerebellum called the right posterior-inferiorcerebellar artery 200 and then joins together with the V4 segment of the leftvertebral artery 255 at the vertebro-basilar junction 205 to form thebasilar artery 210. Thebasilar artery 210 gives off several branches including the bilateral anterior inferiorcerebellar arteries cerebellar arteries basilar apex 225 into the bilateral posteriorcerebral arteries posterior communicating artery 95 communicates with the right posterior cerebral artery 230 (seeFIG. 4 for further details). The leftposterior communicating artery 170 communicates with the left posterior cerebral artery 235 (seeFIG. 4 for further details). The leftvertebral artery 70 is a branch of the leftsubclavian artery 65. The first portion of the left vertebral artery in the cervical or neck portion is called the V1 segment of the leftvertebral artery 70. The left vertebral artery continues in the neck as the V2 segment of the leftvertebral artery 265 and travels close to the base of brain. It makes a tortuous curve and is called the V3 segment of the leftvertebral artery 260 and finally pierces the dura or outer covering layer of the brain and forms the V4 segment of the leftvertebral artery 255. The V4 segment of the leftvertebral artery 255 gives off an important branch to the left cerebellum called the left posterior-inferiorcerebellar artery 250 and then joins together with the V4 segment of the rightvertebral artery 195 at the vertebro-basilar junction 205 to form thebasilar artery 210. - In this invention, the vertebral arteries from the V2, V3, and V4 segments and their branches, along with the basilar artery and the bilateral posterior cerebral arteries and their branches are also considered as cerebral arterial blood vessels (185 to 265).
-
FIG. 4 is a schematic diagram illustrating the main collateral pathways and communications between the cerebral arterial blood vessels including the internal carotid artery system (90 to 170) as well as the vertebro-basilar artery system (205 to 245), and this is known as the Circle of Willis. The supraclinoid portion of the right internalcarotid artery 90 gives off the rightposterior communicating artery 95 which anastomoses or communicates with the right posteriorcerebral artery 230 and helps form the posterior part of the circle of Willis. The supraclinoid portion of the right internalcarotid artery 90 then bifurcates 100 into the right middlecerebral artery 105 as well as the right anteriorcerebral artery 120 at the right internalcarotid artery bifurcation 100. The A1 segment of the right anteriorcerebral artery 120 further continues as the A2 segment of the right anteriorcerebral artery 125 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicatingartery 130 that anastomoses or communicates with the junction of theA1 segment 140 andA2 segments 135 of the left anterior cerebral artery and helps form the anterior part of the circle of Willis. The supraclinoid portion of the left internalcarotid artery 165 gives off the leftposterior communicating artery 170, which anastomoses or communicates with the left posteriorcerebral artery 235 and helps form the posterior part of the circle of Willis. The supraclinoid portion of the left internalcarotid artery 165 then bifurcates 145 into the left middlecerebral artery 150 as well as the left anteriorcerebral artery 140 at the left internalcarotid artery bifurcation 145. The A1 segment of the left anteriorcerebral artery 140 further continues as the A2 segment of the left anteriorcerebral artery 135 and at the junction of the A1 and A2 segments gives off an important branch called the anterior communicatingartery 130 that communicates with the junction of theA1 segment 120 andA2 segments 125 of the right anterior cerebral artery and helps form the anterior part of the circle of Willis. The anterior 130 and posterior communicatingarteries FIG. 2 for further details on the course of the internal carotid arteries and seeFIG. 3 for further details on the course of the vertebral arteries). There are numerous anatomic variations to this and can play an important role at the time of a stroke. -
FIG. 5 illustrates an introducer system to deliver the distal embolic protection device into the microcatheter. Themicroguidewire 290 that contains the distal embolic protection device is housed in a protectivespiral polymer case 270 to avoid kinks or bends in the microguidewire. The spiral loops of the protective polymer case are kept together byclasps 275. The proximal end of the microguidewire is at the inner end of the spiral polymer case. The distal end of the microguidewire with the distal embolic protection device are kept in anintroducer sheath 305 that is made out of a polymer (such as Teflon) and the portion of theintroducer sheath 310 directly overlying the distal embolic protection device and protecting it is shown in this figure. The proximal end of the introducer sheath has ahemostatic valve 295 and a port for attaching a salineflush syringe 300 to be able to saline flush the introducer sheath as well as the distal embolic protection device of any air. The distal end of theintroducer sheath 315 is the part that helps feed the distal embolic protection device into the microcatheter. When the distal protection device needs to be loaded into the microcatheter, the introducer sheath is removed from the clasps, of thespiral polymer case 275 and the microguidewire is slowly pulled off the distal port of thespiral polymer case 285. -
FIG. 6 illustrates theintroducer sheath 305 as well as the portion of the distal end of theintroducer sheath 310 directly overlying the distal embolic protection device and protecting it. When thesaline syringe 325 is connected to port 300 of the introducer sheath and is flushed, then the hemostatic valve is locked at theproximal end 295, and saline drops 320 will be noted to arise from the tip of theintroducer sheath 315 because of saline moving in thedirection 330 of the tip of theintroducer sheath 315 suggesting that theintroducer sheath 305 and the portion of the distal end of theintroducer sheath 310 directly overlying the distal embolic protection device have been flushed of air. -
FIG. 7A illustrates the distal embolic protection device comprising the filtering device in thecollapsed configuration 350 that is back loaded into theintroducer sheath 305 over the microguidewire.FIG. 7B illustrates a magnified view of the distal embolic protection device comprising the filtering device in a collapsed configuration mounted on the variable thickness micro-guidewire. The length of the microguidewire is sufficient for use in existing microcatheters during interventional neurovascular procedures and preferably ranges from 190 to 300 cm in length. The majority of the proximal 290 and distal 335 microguidewire are around 0.014 inch (0.356 mm) in thickness to be compatible with existing microcatheters, balloons and stents that are used in neurovascular interventions. Part of the distal segment of themicroguidewire 335, e.g., 135 cm, is shown in the figure. The distal segment of the microguidewire has athinner segment 360 that is about 0.010 inch (0.254 mm) or less in thickness and this is in the location where the filtering device is mounted. The filtering device is depicted in acollapsed configuration 350. Thethinner segment 360 of the microguidewire where the filtering device is located is much thinner than the rest of themicroguidewire 335 and is no more than about 0.010 inch (0.254 mm) and preferably measures about 0.008 to 0.010 inch (0.203 mm to 0.254 mm) in thickness. This is to maintain a small thin profile of the filtering device in the collapsed or non-expanded configuration within the inner lumen of theintroducer sheath 370 so that the overall thickness of the distal embolic protection device, comprising the microguidewire and filtering device in the collapsed configuration are kept to a thickness less than or equal to 0.017 inch (0.432 mm) to be compatible with existing microcatheters, balloons, and stents. Thethinner segment 360 of the microguidewire meets the thicker segment of the microguidewire at theproximal stop 340 anddistal stop 375. The proximal 340 anddistal stops 375 are no more than about 0.017 inch (0.432 mm) and preferably range from 0.014 inch to 0.017 of an inch (0.356 mm to 0.432 mm). Thefiltering device 350 has proximal 345 and distal 355 attachment points that allow the filtering device to be mobile over the microguidewire in the rotatory and longitudinal directions, relative to the microguidewire. The movement of the filtering device relative to the microguidewire is limited to within the thinner segment of themicroguidewire 360 by the proximal 340 anddistal stops 375. The microguidewire distal 365 to thedistal stop 375 comprises several components that are further described inFIG. 9 and includes ashapeable tip 395, preferably curved, to enable torquability and to avoid wire perforation of a small vessel. The microguidewire may comprise amarker 380 at a predetermined location, e.g. at 135 cm from the distal tip of the microguidewire, to aid in determining when the distal embolic protection device is likely to emerge from the distal end of the microcatheter (normally 135 cm to 175 cm in length) and in determining the progress and location of the distal embolic protection device within the cerebral arterial blood vessel. Preferably the 135 cm marker is visually detectable by the operator so that fluoroscopy can be avoided till approximately 135 cm of the microguidewire has been advanced through the microcatheter. -
FIGS. 8A and 8B illustrate the components of the microguidewire at two lengths namely anexchange length 300 cm (FIG. 8A ) and a non-exchangelength microguidewire length 190 cm respectively (FIG. 8B ). The microguidewire is of variable thickness at the distal end, having a thinner segment to accommodate a distal embolic protection device. The majority of themicroguidewire 335, other than the thinner segment, is of thickness no more than about 0.014 inch (0.356 mm) and is compatible for use with existing microcatheters, balloons, and stents used in neurovascular interventions. A marking 380 on the microguidewire indicates the 135 cm length so that fluoroscopy can be avoided till approximately 135 cm of the microguidewire has been advanced through the microcatheter. The distal segment of the microguidewire, where the filtering device is present, comprises athinner segment 360 having a thickness that is no more than about 0.010 inch (0.254 mm) to accommodate the non-expanded filtering device and still maintain an overall low thickness profile of the distal embolic protection device. The microguidewire has a proximal 340 and distal 375 stop that will allow the filtering device to be stationary in a small cerebral arterial blood vessel despite rotatory and longitudinal motion of the microguidewire over a small distance. The proximal and distal stops have a thickness of no more than about 0.017 inch (0.432 mm) and preferably from 0.014 to 0.017 inch (0.356-0.432 mm). Part of the distal segment of themicroguidewire 335 e.g. distal 30 cm comprises several components that are further described in detail inFIGS. 9A to 9D . The distal end includes adistal tip 365 which may comprise radio-opaque shapeable material to provide some trackability and to retain a curved shape to avoid small vessel perforation.FIG. 8A shows an exchange length microguidewire 300 cm in length.FIG. 8B shows a non-exchange length microguidewire 190 cm in length. The non-exchange length guidewire has a capability at itsproximal end 385 to have anextension microguidewire 390 attached if it needs to be converted into an exchange length microguidewire. -
FIG. 9A is an illustration of an embodiment of the distal segment of the microguidewire e.g. distal 30 cm described inFIG. 8 .FIGS. 9B , 9C and 9D are magnified views of the various components of the distal segment of the variable thickness microguidewire e.g. distal 30 cm. The microguidewire is of variable thickness at the distal segment to accommodate a filtering device at its distal end. The majority of themicroguidewire 335 is no more than about 0.014 inch (0.356 mm) in thickness, and is compatible with existing microcatheters, balloons, and stents used in neurovascular interventions. Themicroguidewire 335 comprises various components including acore microguidewire 334 that runs the entire length of the microguidewire and provides support and trackability that is need for catheterization of the small cerebral arterial blood vessels. The core microguidewire comprises of a metal e.g. stainless steel or an alloy e.g nickel-titanium. The core microguidewire 334 is no more than about 0.014 inch (0.356 mm) in majority of its length in the proximal segment and is tapered to no more than about 0.010 inch (0.254 mm) in the distal segment of the microguidewire e.g distal 30 cm. The distal segment of the microguidewire e.g. distal 30 cm comprises acore microguidewire 334 depicted inFIG. 9B-D that is no more than about 0.010 inch (0.254 mm) in thickness forming the thinner segment of themicroguidewire 360 ofFIGS. 9C-D , and comprises thicker segments proximal to theproximal stop 340 as well as distal to thedistal stop 375, where the core may be coated or covered by another layer or layers, e.g., a coil made up of a radio-opaque material or metal or alloy such as platinum as shown inFIG. 9C forming the shapeable tip of themicroguidewire 395, or aflexible hypotube 336 ofFIG. 9D covering the core microguidewire 334 or a combination of both as shown inFIG. 9D . The coating, or covering, may provide more support as well as trackability that is need for catheterization of the small cerebral arterial blood vessels. The coated core microguidewire is no more than about 0.014 inch (0.356 mm) in thickness in the majority of its length. The various components of this distal segment of the microguidewire are illustrated in more detail inFIGS. 9B to 9D . The thinner segment of themicroguidewire 360 is no more than about 0.010 inch (0.254 mm) to accommodate the filtering device in its non-expanded state and still maintain an overall low thickness profile of the distal embolic protection device. In this thinner segment of the microguidewire where the filtering device is mounted 360, the components of the microguidewire are predominantly just the core microguidewire 334 as previously described. The distal end of themicroguidewire 365 comprises several components that include acore microguidewire 334 as previously described, and a shapeable tip comprising a radio opaque material, metal or alloy, e.g., platinum, that is shapeable to provide some trackability and to retain a curved shape to avoid small vessel perforation. In addition the shapeable tip of the distal end of themicroguidewire 365 may also include a coating or covering layer, such as aflexible hypotube 336, covering the core microguidewire 334 to give it more support and strength and is no more than about 0.014 inch (0.356 mm) in the majority of its length. The microguidewire has proximal 340 and distal 375 stops that allow the filtering device to be stationary in a small cerebral blood vessel despite rotatory and longitudinal motion of the microguidewire relative to the filtering device between the proximal and distal stops. The thickness of the stops is no more than about 0.017 inch (0.432 mm) and preferably from 0.014 to 0.017 inch (0.356-0.432 mm). - Various components of the variable thickness microguidewire may be made up of materials that are biocompatible or surface treated to produce biocompatibility. Suitable materials include e.g., stainless steel, platinum, titanium and its alloys including nickel-titanium, etc. Suitable materials also include a combination of metals and alloys such that the core of the
microguidewire 334 forming thethinner segment 360 could be made from metals or alloys such as stainless steel or nickel-titanium etc. In order to provide a shapeable tip that has some trackability, and that has the capacity to retain a curved shape to avoid small vessel perforation, as well as be visible during neurovascular interventional procedures, the distal end of thecore microguidewire 334 is preferably covered by a coating of a radio-opaque material or metal or alloy, e.g., platinum. To provide more support to the core microguidewire to be able to advance the microguidewire along with the filtering device through a microcatheter, thecore microguidewire 334 may have a coating or covering layer, e.g., a flexible hypotube, and made of metals or alloys, e.g., nickel, titanium, platinum, tungsten etc. In the areas where the microguidewire needs to be visible namely the parts of the distal segment of themicroguidewire 335 e.g. distal 30 cm and the distal tip of themicroguidewire 365 including the twostops -
FIG. 10 is an illustration of one of the embodiments of the distal embolic protection device comprising the filtering device and the microguidewire. The filtering device has a proximal 345 and distal 355 attachment points that are also the sliding or mobile components of the filtering device. These mobile attachment points have a capacity to allow the microguidewire to rotate 430 as well as move back and forth in thelongitudinal direction 435 between the two stops in the microguidewire (340, 375) while keeping the filtering device stationary in a small cerebral blood vessel and thereby decrease friction and trauma on the cerebral blood vessel walls. - The filtering device of the distal embolic protection device of this invention may comprise a filter membrane and an expansion assembly capable of assuming an expanded configuration and a collapsed configuration. Preferably the expansion assembly comprises a plurality of struts (400, 405, 410) that connect the
proximal attachment point 345 to thedistal attachment point 355. The filter membrane may be attached to the struts and the distal attachment point, and in the expanded configuration the filter membrane has a hemispherical shape covering the struts. - The struts comprise a biocompatible material or materials that are surface treated for biocompatibility. The materials are preferably self-expanding. Suitable materials include but are not limited to stainless steel, titanium and its alloys, cobalt-chromium alloy, carbon fiber and its composites, and various biomedical polymers, e.g., polyurethane, polyethylene, polyester, polypropylene, poly tetra fluoro-ethylene, polyamides, polycarbonate or polyethylene-terephthalate. A shape memory or super-elastic material such as nickel-titanium alloy is also suitable. The number of struts will depend on the size of expansion needed for the diameter of the cerebral blood vessel. The distal embolic protection device will be suitable for use in cerebral blood vessels from vessel diameters of 1.5 mm to 4.5 mm.
- In addition to the two stops in the
microguidewire filtering device struts 400 to 410, or parts of thefilter membrane 415 may be radio-opaque. Radio-opaque materials are understood as materials that are visible on a fluoroscopy screen during neurovascular interventional procedures. This allows the operator to determine the location of the device during neurovascular interventions. Radio-opaque materials include, e.g., metals or alloys including but are not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above etc. The struts may comprise metals or alloys that are radio-opaque, e.g., platinum or the others listed above. Alternatively the struts may comprise shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque but small portions of radio-opaque metals or alloys, e.g., tantalum, can be attached to non-radio-opaque struts by suturing the filter membrane to the struts with tantalum wires or other suitable radio-opaque material. - The filtering device also comprises a
filter membrane 415 for collecting emboli or debris that might be released during the neurovascular intervention. The filter membrane may comprise a biomedical polymer, e.g., polyurethane (BioSpan™ made by Polymer Technology Group and Chronoflex™ made by CardioTech International), polyethylene (Rexell™ made by Huntsman), polypropylene (Inspire™ made by Dow), polyester (Hytril™ made by Dupont), poly tetra fluoro-ethylene (Teflon™ made by Dupont), polyamides (Durethan™ made by Bayer), polycarbonate (Corethane™ made by Corvita Corp), or polyethylene-terephthalate (Dacron™ made by Dupont). The filter membrane may further comprise a radio-opaque material, e.g., particles of tantalum, particles of gold, other radio-opaque agents, e.g., barium sulfate, tungsten powder, bismuth subcarbonate, bismuth oxychloride, iodine containing agents such as iohexol (Omnipaque™ made by Amersham Health). The filter membrane comprisespores 420 that are of the dimensions small enough to trap emboli or debris but large enough to allow the free passage of blood and its components such as blood cells preferably the pores are of 50 microns to 150 microns. Thearrows 425 indicate the direction of blood flow within the blood vessel. - The microguidewire is thinner between the two radio-
opaque stops thin segment 360, the microguidewire thickness is no more than about 0.010 inch (0.254 mm). This is to allow for the thickness of the filtering device comprising the struts such that in its non-expanded state the distal embolic protection device overall is no more than about 0.017 inch (0.432 mm). This is to enable the distal embolic protection device to be delivered through standard microcatheters that are commercially available (such as Echelon™ microcatheter, ev3 Inc; Excelsior™ microcatheter, Boston Scientific Corp; Prowler™ microcatheter, Cordis Neurovascular etc) that have an internal diameter of around 0.017 inch (0.432 mm). -
FIG. 11 is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described inFIG. 10 . Some of thestruts filter membrane 415 is depicted with a hemispherical shape covering the struts. Themicroguidewire 360 passing through the center of the filtering device as well as thedistal attachment point 355 of the filtering device are also shown. -
FIG. 12 is an illustration showing the distal embolic protection device described inFIG. 10 in an expanded configuration showing the radio-opaque components under fluoroscopy. The distal segment of themicroguidewire 335 e.g. distal 30 cm is radio-opaque along with theproximal stop 340 and are made of radio-opaque metals or alloys, e.g., platinum, as mentioned in description ofFIGS. 8A , 8B and 10. The microguidewire in thethinner segment 360 is not radio-opaque and is made up of a metal or alloy, e.g., nickel-titanium or stainless steel. Thedistal stop 375 as well as the distal end of themicroguidewire 365 including theshapeable tip 395 are also made of a radio-opaque metal or alloy such as platinum as described in detail inFIGS. 8A , 8B, and 10. Portions of thestruts 400 to 410 of the distal embolic protection device described inFIG. 10 are also made of a radio-opaque metal or alloy, e.g., platinum, or have a covering with a radio-opaque material, e.g., tantalum as described inFIG. 10 in detail. This enables the operator performing the neurovascular interventional procedure to clearly visualize the deployed distal embolic protection device as well as the position of the microguidewire. -
FIG. 13 is an illustration of another embodiment of a distal embolic protection device of this invention comprising a filtering device rotatably mounted on a variable-thickness microguidewire. The filtering device has proximal 345 and distal 355 attachment regions that are also the sliding or mobile components of the distal embolic protection device. These mobile attachment points have a capacity to allow the microguidewire to rotate 430 as well as move back and forth in thelongitudinal direction 435 between the two stops in the microguidewire (340, 375) while keeping the distal embolic protection device stationary in a small cerebral blood vessel and thereby help decrease friction and trauma on the cerebral blood vessel walls. The distal embolic protection device in this embodiment comprises an expansion assembly comprising a plurality of struts (400, 405, 410) that connect theproximal attachment point 345 to thedistal attachment point 355 and are capable of assuming an expanded configuration and a collapsed configuration The expanded configuration of the plurality of struts and the filter membrane having a hemispherical shape is depicted. The distal embolic protection device further comprises twocylindrical coils Cylindrical coil 436 connects theproximal stop 340 to theproximal attachment point 345 of the filtering device.Cylindrical coil 437 connects thedistal attachment point 355 of the filtering device to thedistal stop 375 of the microguidewire. The cylindrical coils allow forrotatory 430 as well aslongitudinal movement 435 of the filtering device relative to the microguidewire in the thinner segment of themicroguidewire 360. The cylindrical coils decrease the shear stress on the thinner segment of themicroguidewire 360 when the distal embolic protection device is recovered with a microcatheter, balloon catheter or stent catheter. The coils provide added support to the thinner segment of themicroguidewire 360 and reduce fracture or stretching of the microguidewire at the region of theproximal stop 340 ordistal stop 375. The cylindrical coils may be made of a biocompatible material, or a material that is surface treated to be biocompatible and may comprise radio-opaque metals or alloys, e.g., platinum, as described in detail inFIG. 10 . -
FIG. 14A is an illustration of another of the embodiments of the filtering device attached to the microguidewire. The filtering device comprises proximal 455 and distal 460 attachment points that are also the sliding or mobile components of the distal embolic protection device. These mobile attachment points have a capacity to allow the microguidewire to rotate 490 as well as movelongitudinal direction 495 between the two proximal and distal stops of the microguidewire (340, 375) while the filtering device remains stationary in the small cerebral blood vessel and thereby help to decrease friction and trauma on the cerebral blood vessel walls. The distal embolic protection device in this embodiment comprises a filter membrane attached to the distal end of the filtering device and an expansion assembly comprising a plurality ofstruts proximal attachment point 455 of the filtering device to the distal attachment point of thefiltering device 460. The plurality of struts in the expanded configuration and the filter membrane having a helical or conical shape and covering the struts is also depicted. - The struts, preferably made of a biocompatible material or a material that is surface treated to be biocompatible and preferably made of a self-expanding material, are detailed in the embodiment described in
FIG. 10 . Suitable materials include but are not limited to stainless steel, titanium and its alloys, cobalt-chromium alloy, carbon fiber and its composites, and various polymers. A shape memory or super-elastic material such as nickel-titanium alloy is also suitable. The number of struts will depend on the size of expansion needed for the diameter of the cerebral blood vessel. The distal embolic protection device will be suitable for use in cerebral blood vessels from vessel diameters 1.5 mm to 4.5 mm. - In addition to the two stops in the
microguidewire filtering device struts filter membrane 480 may be radio-opaque. Radio-opaque materials are understood to be materials that are visible on a fluoroscopy screen during neurovascular interventional procedures. This allows the operator to determine the location of the device during neurovascular interventions. Radio-opaque materials include metals or alloys including but are not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above. The struts can be made of metals or alloys that are radio-opaque, e.g., platinum or the others listed above. Alternatively the struts are made of shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque, and may further comprise small portions of radio-opaque metals or alloys such as tantalum, that can be attached to the non-radio-opaque struts by suturing the filter membrane to the struts with a radio-opaque material, e.g. tantalum wires etc. - The filtering device comprises a
filter membrane 480 to capture emboli or debris that might be released during the neurovascular intervention. The filter membrane is preferably a biomedical polymer, e.g., polyurethane (BioSpan™ made by Polymer Technology Group and Chronoflex™ made by CardioTech International), polyethylene (Rexell™ made by Huntsman), polypropylene (Inspire™ made by Dow), polyester (Hytril™ made by Dupont), poly tetra fluoro-ethylene (Teflon™ made by Dupont), polyamides (Durethan™ made by Bayer), polycarbonate (Corethane™ made by Corvita Corp), or polyethylene-terephthalate (Dacron™ made by Dupont). The filter membrane may further comprise a radio-opaque material, e.g., particles of tantalum, particles of gold, other radio-opaque agents such as barium sulfate, tungsten powder, bismuth subcarbonate, bismuth oxychloride, iodine containing agents such as Omnipaque™. The filter haspores 485 that are small enough to trap emboli or debris but large enough to allow the free passage of blood and its components such as blood cells, preferably the pores are 50 microns to 150 microns in diameter. Thearrows 500 indicate the direction of blood flow within the cerebral blood vessel. - The microguidewire is thinner between the two radio-
opaque stops thinner segment 360, the microguidewire thickness is no more than about 0.010 inch (0.254 mm). This is to accommodate the filtering device such that in its non-expanded configuration the thickness of the filtering device is less than or equal to 0.017 inch (0.432 mm). This is to enable the distal embolic protection device to be delivered through standard microcatheters that are commercially available (such as Echelon™ microcatheter, ev3 Inc; Excelsior™ microcatheter, Boston Scientific Corp; Prowler™ microcatheter, Cordis Neurovascular etc) that have an internal diameter of about 0.017 inch (0.432 mm). -
FIG. 14B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described inFIG. 14A . Thestruts 465 to 475 are depicted in an expanded configuration, providing the filtering device with a helical or conical shape. Thefilter membrane 480 is depicted as covering thestruts microguidewire 360 passing through the center of the filtering device as well as thedistal attachment point 460 of the filtering device are shown. -
FIG. 15A is an illustration of another embodiment of the distal embolic protection device. The filtering device has proximal 535 and distal 530 attachment points that are also the sliding or mobile components of the filtering device. These mobile attachment points have a capacity to allow the microguidewire to rotate 565 as well as move back and forth in thelongitudinal direction 570 relative to the filtering device between the two stops in the microguidewire (340, 375) while keeping the filtering device stationary in a small cerebral blood vessel and thereby decrease friction and trauma on the cerebral blood vessel walls. The filtering device in this embodiment comprises afilter membrane 555 and aring 525. The filter membrane is attached to the ring and the ring is connected to theproximal attachment point 535. The ring in turn comprises a plurality ofstruts ring 525 to thedistal attachment point 530. The ring and if present the plurality of struts when expanded can provide the filtering device with a conical shape. - The ring, and if present the plurality of struts, are made of biocompatible materials or materials that are surface treated such that they are biocompatible. The materials are preferably self-expanding as described in
FIG. 10 . Suitable materials include but are not limited to stainless steel, titanium and its alloys, cobalt-chromium alloy, carbon fiber and its composites, and various polymers. A shape memory or super-elastic material such as nickel-titanium alloy is also suitable. The number of struts will depend on the size of expansion needed for the diameter of the cerebral blood vessel to be treated. The distal embolic protection devices of this invention are suitable for use in cerebral blood vessels from vessel diameters 1.5 mm to 4.5 mm. - In addition to the two stops in the
microguidewire device ring 525, or parts of thefilter membrane 555 may further comprise a radio-opaque material. Radio-opaque materials are understood as materials that are visible on a fluoroscopy screen during neurovascular interventional procedures. This allows the operator to determine the location of the device during neurovascular interventions. Radio-opaque materials can include metals or alloys, including but not limited to platinum, tantalum, gold, palladium, tungsten, tin, silver, titanium, nickel, zirconium, rhenium, bismuth, molybdenum, or combinations of the above etc. The struts can be made up of metals or alloys that are radio-opaque such as platinum or the others listed above. Alternatively the struts may be made of shape-elastic alloys such as nickel-titanium, which are not significantly radio-opaque, but may be made radio-opaque by attaching small portions of radio-opaque metals or alloys, e.g., tantalum, to the non-radio-opaque struts by suturing the filter membrane to the struts with a radio-opaque material, e.g., tantalum wires etc. - The filtering device comprises a
filter membrane 555 that extends from thering 525 to thedistal attachment point 530 and acts as a filter for emboli or debris that might be released during the neurovascular intervention. The filter membrane may cover the struts. Materials for this filter include but are not limited to biomedical polymers such as, e.g., polyurethane (BioSpan™ made by Polymer Technology Group and Chronoflex™ made by CardioTech International, polyethylene (Rexell™ made by Huntsman), polypropylene (Inspire™ made by Dow), polyester (Hytril™ made by Dupont), poly tetra fluoro-ethylene (Teflon™ made by Dupont), polyamides (Durethan™ made by Bayer), polycarbonate (Corethane™ made by Corvita Corp), or polyethylene-terephthalate (Dacron™ made by Dupont). The filter haspores 560 that are small enough to trap emboli or debris but large enough to allow the free passage of blood and its components such as blood cells. Preferably the pores are 50 microns to 150 microns. Thearrows 575 indicate the direction of blood flow with the cerebral blood vessel. The filter membrane may further comprise radio-opaque materials, e.g., as particles of tantalum, particles of gold, other radio-opaque agents, e.g., barium sulfate, tungsten powder, bismuth subcarbonate, bismuth oxychloride, iodine containing agents such as Omnipaque™. - The microguidewire is thinner between the two radio-
opaque stops thinner segment 360, the microguidewire thickness is no more than about 0.010 inch (0.254 mm). This is to allow for the thickness of the distal embolic protection device, the ring and the struts if present such that in the non-expanded state the ring of the distal embolic protection device is no more than about 0.017 inch (0.432 mm). This is to enable the distal embolic protection device to be delivered through standard microcatheters that are commercially available (such as Echelon™ microcatheter, ev3 Inc; Excelsior™ microcatheter, Boston Scientific Corp; Prowler™ microcatheter, Cordis Neurovascular etc) that have an internal diameter of about 0.017 inch (0.432 mm). -
FIG. 15B is a schematic diagram illustrating the cross-sectional view of the distal embolic protection device described inFIG. 15A . The radio-opaque ring is shown 525 and is attached to afilter membrane 555 connecting the ring to thedistal attachment point 530. The filter membrane has micro-pores 560. In one of the embodiments of this device, there is also a plurality ofstruts 540 to 550 connecting thering 525 to the distal attachment point. Themicroguidewire 360 passing through the side of the filtering device as well as the proximal 535 and distal attachment points 530 of the filtering device are shown. -
FIG. 16 is a schematic diagram illustrating a significant blockage orstenosis 585 in the right middlecerebral artery 105 that is causing mini-strokes and is refractory to medical therapy. A guide catheter (6 French or larger) 580 has been advanced into the right internalcarotid artery 30 so that intracranial balloon angioplasty and stenting can be performed. -
FIG. 17 is a schematic diagram illustrating that through the guide catheter in the right internal carotid artery, amicrocatheter 590 is being advanced in the right internal carotid artery into the right middle cerebral artery over amicrowire 600. The microwire is carefully advanced across the blockage in the right middlecerebral artery 585. The microcatheter is then advanced over the microwire. -
FIG. 18 is a schematic diagram illustrating that themicrocatheter 590 has been carefully advanced across the blockage in the right middlecerebral artery 585 over a microwire. The microwire has been removed once the microcatheter is distal to theblockage 585 in the right middle cerebral artery. Prior to exchanging the microcatheter for a balloon catheter, a distal embolic protection device is decided to be advanced to the right middle cerebral artery through the microcatheter. -
FIG. 19 is a schematic diagram illustrating theintroducer sheath 305 with the non-expanded distalembolic protection device 310 comprisingmicroguidewire 290 are being advanced through themicrocatheter 590. Thehemostatic valve 295 at the proximal end of the introducer sheath is released so that themicroguidewire 290 can be advanced. Once the distalembolic protection device 310 has entered themicrocatheter 590 and guidecatheter 580, theintroducer sheath 305 can be removed. Theguide catheter 580 is connected to a rotatinghemostatic valve 595 to prevent back-bleeding. Themicrocatheter 590 passes through the rotatinghemostatic valve 595 and then into theguide catheter 580. -
FIG. 20 is a schematic diagram illustrating the distalembolic protection device 350 in the non-expanded state in the appropriate location distal to theblockage 585 in the right middle cerebral artery. With themicroguidewire 365 in position and fixed, themicrocatheter 590 is being withdrawn to deploy the filtering device. The tip of themicroguidewire 395 is shaped to avoid perforating a small vessel. Thedistal stop 375 in the microguidewire acts as the radio-opaque marker. -
FIG. 21 is a schematic diagram illustrating the distal embolic protection device fully deployed in the right middle cerebral artery distal to theblockage 585. The radio-opaque distal part of themicroguidewire 365 along with theshapeable tip 395 are noted. The radio-opaque stops of themicroguidewire struts attachment points filter membrane 415 is noted. With the microguidewire fixed in position, themicrocatheter 590 is being exchanged for a balloon catheter so that intracranial balloon angioplasty can be performed. -
FIG. 22 is a schematic diagram illustrating the filtering device is in place distal to theblockage 585 in the right middle cerebral artery. With the microguidewire in position, the microcatheter is exchanged for aballoon catheter 605. The mobile attachment points 345 and 355 of the filtering device allow for the filtering device to be stationary even if there is minimal movement of themicroguidewire 335 during the microcatheter exchange. When theballoon 610 is across theblockage 585 in the right middle cerebral artery, intracranial balloon angioplasty is performed. During intracranial balloon angioplasty, emboli or debris are released 615 and are collected in the distal embolic protection device by thefilter 415. -
FIG. 23 is a schematic diagram illustrating that after intracranial angioplasty, theballoon 610 shown inFIG. 22 is deflated and theballoon catheter 605 is exchanged for anintracranial stent catheter 620 over the microguidewire. When the stent is in position across the area ofblockage 630 in the right middle cerebral artery where balloon angioplasty was performed, the stent is deployed. During intracranial stenting, small emboli or debris are released 615 and are collected in thefilter 415 of the distal embolic protection device. After stenting is performed, the distal embolic protection device can be retrieved using thestent catheter 620 by advancing it over the microguidewire till the radio-opaque markers in struts of the distal embolic protection device suggest that the filter has closed so that the device can be safely removed. -
FIG. 24 is a schematic diagram illustrating a standard microcatheter, which can be alternatively used to retrieve the distal embolic protection device. In this case, thestent catheter 620 shown inFIG. 23 is exchanged for astandard catheter 590 over themicroguidewire 335. The standard microcatheter has a proximal 640 anddistal end 645. Standard microcatheters that are commercially available (such as Echelon™ microcatheter, ev3 Inc; Excelsior™ microcatheter, Boston Scientific Corp; Prowler™ microcatheter, Cordis Neurovascular etc) can be used and their inner lumen diameter range from 0.017 to 0.021 inch (0.432 mm to 0.533 mm) and are usually 135 to 175 cm in length. -
FIG. 25 is a schematic diagram illustrating the tip of thestandard microcatheter 645 being advanced over the microguidewire such that thefiltering device 350 closes to the collapsed configuration to prevent spillage of the emboli or debris collected during the procedure. The stent is noted to be ingood position 625 across theangioplastied area 630. -
FIG. 26 is a schematic diagram illustrating thefiltering device 350 in the closed non-expanded state being carefully withdrawn into theguide catheter 580. Themicrocatheter tip 645 is closely approximated to the struts of the filtering device to prevent spillage of the contents of the distal embolic protection device namely emboli or debris. The stent is noted to be ingood position 625 across theangioplastied area 630. -
FIG. 27 is a schematic diagram illustrating another use for this distal embolic protection device. This figure illustrates a thrombus orblood clot 650 in the right middle cerebral artery and is occluding this right middle cerebral artery and causing an acute ischemic stroke. The patient presents after 3 hours from symptom onset and is a candidate for immediate neurovascular interventional therapy with intra-arterial thrombolytic infusion. A guide catheter 580 (6 French or greater) is advanced into the right internal carotid artery. -
FIG. 28 is a schematic diagram illustrating astandard microcatheter 590 being advanced across the thrombus orblood clot 650 in the right middle cerebral artery over amicrowire 600. Once the microcatheter is across the thrombus or blood clot, the microwire will be removed and a microcatheter angiogram may be performed to identify if the cerebral blood vessels distal to the thrombus or blood clot are patent. -
FIG. 29 is a schematic diagram illustrating a distal embolic protection device is advanced through themicrocatheter 590 into a position distal to the thrombus orblood clot 650 and then the microcatheter is withdrawn to the proximal part of the right middle cerebral artery to deploy the distal embolic protection device. The radio-opaque stops opaque microguidewire segment 365 and theshapeable tip 395 are well visualized. Intra-arterial thrombolytic infusion is initiated through the microcatheter with the microguidewire inposition 335. The thrombus or blood clot is broken down 655 into smaller emboli ordebris 660, which are collected in thefilter membrane 480 of the distal protection device. Thestruts 470 of the distal embolic protection device are in the expanded position to maintain the shape of the filter membrane. -
FIG. 30 is a schematic diagram illustrating after intra-arterial thrombolysis, themicrocatheter 590 is advanced over the microguidewire such that thefiltering device 350 closes to the collapsed configuration to prevent spillage of the emboli or debris collected during the procedure. Thefiltering device 350 in the closed non-expanded state is then carefully withdrawn into theguide catheter 580. All through the process, themicrocatheter tip 645 is closely approximated to the struts of the distal embolic protection device to prevent spillage of the contents of the distal embolic protection device namely emboli or debris. - While the invention is susceptible to various modifications, and alternative forms, specific examples thereof have been shown in the drawings and are herein described in detail. It should be understood, however, that the invention is not to be limited to the particular forms or methods disclosed, but to the contrary, the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the appended claims.
-
- 1. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke. 2000; 31:1588-1601.
- 2. Wolf P A, D'Agostino R B. Epidemiology of Stroke. In: Barnett H J M, Mohr J P, Stein B M, Yatsu F, eds. Stroke: Pathophysiology, Diagnosis, and Management. 3rd ed. New York, N.Y.: Churchill Livingstone; 1998:6-7
- 3. Adams H P, Jr., Adams R J, Brott T, del Zoppo G J, Furlan A, Goldstein L B, Grubb R L, Higashida R, Kidwell C, Kwiatkowski T G, Marler J R, Hademenos G J. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003; 34:1056-1083.
- 4. Rymer M M, Thrutchley D E. Organizing regional networks to increase acute stroke intervention. Neurol Res. 2005; 27:S9-16.
- 5. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark W M, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. Jama. 1999; 282:2003-2011.
- 6. Yadav J S. Carotid stenting in high-risk patients: design and rationale of the SAPPHIRE trial. Cleve Clin J Med. 2004; 71 Suppl 1:S45-46.
- 7. Bose A, Hartmann M, Henkes H, Liu H M, Teng M M, Szikora I, Berlis A, Reul J, Yu S C, Forsting M, Lui M, Lim W, Sit S P. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007; 38:1531-1537. Epub 207 March 1529.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/709,794 US20150238303A1 (en) | 2007-09-21 | 2015-05-12 | Variable thickness vascular treatment device systems and methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/859,272 US9034007B2 (en) | 2007-09-21 | 2007-09-21 | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US14/709,794 US20150238303A1 (en) | 2007-09-21 | 2015-05-12 | Variable thickness vascular treatment device systems and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/859,272 Continuation US9034007B2 (en) | 2007-09-21 | 2007-09-21 | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150238303A1 true US20150238303A1 (en) | 2015-08-27 |
Family
ID=40468238
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/859,272 Active 2028-06-11 US9034007B2 (en) | 2007-09-21 | 2007-09-21 | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US14/709,794 Abandoned US20150238303A1 (en) | 2007-09-21 | 2015-05-12 | Variable thickness vascular treatment device systems and methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/859,272 Active 2028-06-11 US9034007B2 (en) | 2007-09-21 | 2007-09-21 | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
Country Status (2)
Country | Link |
---|---|
US (2) | US9034007B2 (en) |
WO (1) | WO2009038799A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9314324B2 (en) | 2013-03-15 | 2016-04-19 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US9592068B2 (en) | 2013-03-15 | 2017-03-14 | Insera Therapeutics, Inc. | Free end vascular treatment systems |
US9750524B2 (en) | 2013-03-15 | 2017-09-05 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy systems |
US9833251B2 (en) | 2013-03-15 | 2017-12-05 | Insera Therapeutics, Inc. | Variably bulbous vascular treatment devices |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8414543B2 (en) | 1999-10-22 | 2013-04-09 | Rex Medical, L.P. | Rotational thrombectomy wire with blocking device |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US10850235B2 (en) | 2006-10-09 | 2020-12-01 | Minnetronix, Inc. | Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow |
US10632237B2 (en) | 2006-10-09 | 2020-04-28 | Minnetronix, Inc. | Tangential flow filter system for the filtration of materials from biologic fluids |
EP3827841B1 (en) | 2006-10-09 | 2024-04-03 | Neurofluidics, Inc. | Cerebrospinal fluid purification system |
US9107734B2 (en) | 2006-11-29 | 2015-08-18 | Emboline, Inc. | Embolic protection device |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US20100022951A1 (en) * | 2008-05-19 | 2010-01-28 | Luce, Forward, Hamilton 7 Scripps, Llp | Detachable hub/luer device and processes |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
AU2009217354B2 (en) | 2008-02-22 | 2013-10-10 | Covidien Lp | Methods and apparatus for flow restoration |
CN101977650A (en) | 2008-04-11 | 2011-02-16 | 曼德弗雷姆公司 | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
EP2539012B1 (en) | 2010-02-23 | 2018-01-24 | Covidien LP | Devices for vascular recanalization |
EP2739217B1 (en) | 2011-08-05 | 2022-07-20 | Route 92 Medical, Inc. | Systems for treatment of acute ischemic stroke |
US10779855B2 (en) | 2011-08-05 | 2020-09-22 | Route 92 Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
WO2013063124A1 (en) | 2011-10-25 | 2013-05-02 | Boston Scientific Scimed, Inc. | Embolic debris deflector |
US8968354B2 (en) | 2011-10-26 | 2015-03-03 | Boston Scientific Scimed, Inc. | Extended protection embolic filter |
CA3082787C (en) | 2011-12-06 | 2021-03-09 | Aortic Innovations Llc | Device for endovascular aortic repair and method of using the same |
WO2013103979A1 (en) | 2012-01-06 | 2013-07-11 | Emboline, Inc. | Integrated embolic protection devices |
US8574170B2 (en) * | 2012-04-06 | 2013-11-05 | Covidien Lp | Guidewire |
US9358021B2 (en) | 2013-01-09 | 2016-06-07 | Covidien Lp | Connection of an endovascular intervention device to a manipulation member |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
US8900265B1 (en) * | 2014-01-03 | 2014-12-02 | Legacy Ventures LLC | Clot retrieval system |
US9820761B2 (en) | 2014-03-21 | 2017-11-21 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system and method |
WO2016010996A1 (en) * | 2014-07-15 | 2016-01-21 | Stryker Corporation | Vascular access system and method of use |
JP6245760B2 (en) * | 2014-09-16 | 2017-12-13 | 朝日インテック株式会社 | Guide wire |
US10279094B2 (en) * | 2015-01-21 | 2019-05-07 | United States Of America As Represented By The Secretary Of The Air Force | Endovascular variable aortic control catheter |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
ES2770321T3 (en) | 2015-02-04 | 2020-07-01 | Route 92 Medical Inc | Rapid Aspiration Thrombectomy System |
US11147540B2 (en) | 2015-07-01 | 2021-10-19 | Minnetronix, Inc. | Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue |
WO2017019564A1 (en) | 2015-07-24 | 2017-02-02 | Route 92 Medical, Inc. | Methods of intracerebral implant delivery |
WO2017019563A1 (en) | 2015-07-24 | 2017-02-02 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
US10537344B2 (en) | 2015-10-23 | 2020-01-21 | Covidien Lp | Rotatable connection between an intervention member and a manipulation member of an endovascular device |
EP3842080B1 (en) | 2015-12-04 | 2023-04-12 | Minnetronix Inc. | Systems for the conditioning of cerebrospinal fluid |
WO2018132387A1 (en) | 2017-01-10 | 2018-07-19 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
CN106730251A (en) * | 2017-01-11 | 2017-05-31 | 仇汉诚 | A kind of micro-wire |
WO2018156948A1 (en) | 2017-02-23 | 2018-08-30 | Boston Scientific Scimed, Inc. | Medical drain device |
US11491313B2 (en) | 2018-02-20 | 2022-11-08 | Crossliner, Inc. | Guide catheter extension system with a delivery micro-catheter configured to facilitate percutaneous coronary intervention |
US20190255299A1 (en) * | 2018-02-20 | 2019-08-22 | Crossliner, Llc | Intravascular delivery system and method for percutaneous coronary intervention |
US11642500B2 (en) | 2018-02-20 | 2023-05-09 | Crossliner, Inc. | Intravascular delivery system and method for percutaneous coronary intervention |
US11607523B2 (en) | 2018-05-17 | 2023-03-21 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
EP3923861A4 (en) | 2019-02-13 | 2022-11-09 | Emboline, Inc. | Catheter with integrated embolic protection device |
US11738188B2 (en) | 2020-06-08 | 2023-08-29 | Covidien Lp | Connection of intravascular interventional elements and elongate manipulation members |
US20220192689A1 (en) * | 2020-12-21 | 2022-06-23 | Fortuna Clinic, LLC | Lesion Crossing Device with Embolic Protection |
US11712266B2 (en) | 2021-06-25 | 2023-08-01 | Vantis Vascular, Inc. | Enhanced guide extension system for the efficient delivery of leads |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030097094A1 (en) * | 2001-11-20 | 2003-05-22 | The Cleveland Clinic Foundation | Apparatus and method for eliminating dislodged thrombus |
US6695813B1 (en) * | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US20050085846A1 (en) * | 2003-10-21 | 2005-04-21 | Scimed Life Systems, Inc. | Clot removal device |
US6964670B1 (en) * | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US20070088383A1 (en) * | 2005-10-03 | 2007-04-19 | Cook Incorporated | Embolic protection device |
US20080147110A1 (en) * | 2006-12-19 | 2008-06-19 | Lalith Hiran Wijeratne | Embolic protection device with distal tubular member for improved torque response |
Family Cites Families (395)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB667071A (en) | 1949-01-24 | 1952-02-27 | Bundy Tubing Co | Improvements in manufacture and cooling of tubing made from longitudinally moving strip stock |
US3381114A (en) | 1963-12-28 | 1968-04-30 | Nippon Electric Co | Device for manufacturing epitaxial crystals |
US3378282A (en) | 1965-12-30 | 1968-04-16 | Amp Inc | Tube coupling |
US3596545A (en) | 1969-06-11 | 1971-08-03 | Conver Maschbau | Automatic machine tool for working elongated material in increments |
US3790744A (en) * | 1971-07-19 | 1974-02-05 | American Can Co | Method of forming a line of weakness in a multilayer laminate |
US4030503A (en) | 1975-11-05 | 1977-06-21 | Clark Iii William T | Embolectomy catheter |
US4334535A (en) | 1980-08-12 | 1982-06-15 | Cutter Laboratories, Inc. | Conduit device for rapid priming and flow of liquid |
US4560378A (en) | 1983-09-06 | 1985-12-24 | Weiland Mary C | Medical accessory |
US4585436A (en) | 1983-11-03 | 1986-04-29 | Baxter Travenol Laboratories, Inc. | Peritoneal dialysis apparatus |
US4778559A (en) | 1986-10-15 | 1988-10-18 | Advantage Production Technology | Semiconductor substrate heater and reactor process and apparatus |
US5171383A (en) | 1987-01-07 | 1992-12-15 | Terumo Kabushiki Kaisha | Method of manufacturing a differentially heat treated catheter guide wire |
US4989606A (en) * | 1987-01-30 | 1991-02-05 | Minnesota Mining And Manufactoring Company | Intravascular blood gas sensing system |
US5211183A (en) | 1987-05-13 | 1993-05-18 | Wilson Bruce C | Steerable memory alloy guide wires |
US4984581A (en) | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
US4964320A (en) | 1988-12-22 | 1990-10-23 | Engineering & Precision Machining, Inc. | Method of forming a beaded transfixion wire |
US5484409A (en) * | 1989-08-25 | 1996-01-16 | Scimed Life Systems, Inc. | Intravascular catheter and method for use thereof |
US6227436B1 (en) | 1990-02-19 | 2001-05-08 | Hitachi, Ltd. | Method of fabricating an electronic circuit device and apparatus for performing the method |
CA2048120A1 (en) | 1990-08-06 | 1992-02-07 | William J. Drasler | Thrombectomy method and device |
US5160342A (en) | 1990-08-16 | 1992-11-03 | Evi Corp. | Endovascular filter and method for use thereof |
US5108419A (en) | 1990-08-16 | 1992-04-28 | Evi Corporation | Endovascular filter and method for use thereof |
CA2048464A1 (en) * | 1990-08-17 | 1992-02-18 | Michael P. Chesterfield | Apparatus and method for producing braided suture products |
US5449372A (en) | 1990-10-09 | 1995-09-12 | Scimed Lifesystems, Inc. | Temporary stent and methods for use and manufacture |
US5265622A (en) | 1990-10-25 | 1993-11-30 | C. R. Bard, Inc. | Guidewire having radially expandable member and method for guiding and advancing a catheter using the same |
US5527292A (en) | 1990-10-29 | 1996-06-18 | Scimed Life Systems, Inc. | Intravascular device for coronary heart treatment |
DE4036570A1 (en) | 1990-11-16 | 1992-05-21 | Osypka Peter | CATHETER FOR REDUCING OR REMOVING CONSTRUCTIONS IN VESSELS |
US6165292A (en) | 1990-12-18 | 2000-12-26 | Advanced Cardiovascular Systems, Inc. | Superelastic guiding member |
AU660444B2 (en) | 1991-02-15 | 1995-06-29 | Ingemar H. Lundquist | Torquable catheter and method |
US5073694A (en) | 1991-02-21 | 1991-12-17 | Synthes (U.S.A.) | Method and apparatus for laser cutting a hollow metal workpiece |
WO1994015661A1 (en) | 1991-05-01 | 1994-07-21 | Rosenberg Paul H | Device and method for inhibiting intravascular device associated infection |
US5879499A (en) * | 1996-06-17 | 1999-03-09 | Heartport, Inc. | Method of manufacture of a multi-lumen catheter |
US6107004A (en) | 1991-09-05 | 2000-08-22 | Intra Therapeutics, Inc. | Method for making a tubular stent for use in medical applications |
CA2117088A1 (en) | 1991-09-05 | 1993-03-18 | David R. Holmes | Flexible tubular device for use in medical applications |
US5741429A (en) | 1991-09-05 | 1998-04-21 | Cardia Catheter Company | Flexible tubular device for use in medical applications |
US6027863A (en) * | 1991-09-05 | 2000-02-22 | Intratherapeutics, Inc. | Method for manufacturing a tubular medical device |
US5195408A (en) * | 1991-09-30 | 1993-03-23 | Westboro Engineering Company, Inc. | Bar feeder with centering apparatus |
CA2380683C (en) * | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
JPH07505316A (en) | 1992-03-31 | 1995-06-15 | ボストン サイエンティフィック コーポレーション | medical wire |
US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
AU3992993A (en) | 1992-11-06 | 1994-05-19 | Chartier, Clifford E | Apparatus for producing sheet waterfall for pool or spa |
US5423849A (en) | 1993-01-15 | 1995-06-13 | Target Therapeutics, Inc. | Vasoocclusion device containing radiopaque fibers |
US5378234A (en) * | 1993-03-15 | 1995-01-03 | Pilot Cardiovascular Systems, Inc. | Coil polymer composite |
US5897567A (en) | 1993-04-29 | 1999-04-27 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
IL105828A (en) | 1993-05-28 | 1999-06-20 | Medinol Ltd | Medical stent |
US5398568A (en) * | 1993-11-22 | 1995-03-21 | General Motors Corporation | Steering wheel for motor vehicle |
EP0679372B1 (en) * | 1994-04-25 | 1999-07-28 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent markers |
US6123715A (en) * | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
JPH10504738A (en) | 1994-07-08 | 1998-05-12 | マイクロベナ コーポレイション | Medical device forming method and vascular embolization device |
WO1996010366A1 (en) | 1994-10-03 | 1996-04-11 | Heart Technology, Inc. | Transluminal thrombectomy apparatus |
CA2163824C (en) | 1994-11-28 | 2000-06-20 | Richard J. Saunders | Method and apparatus for direct laser cutting of metal stents |
US5814062A (en) * | 1994-12-22 | 1998-09-29 | Target Therapeutics, Inc. | Implant delivery assembly with expandable coupling/decoupling mechanism |
US5578074A (en) | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
US5697899A (en) | 1995-02-07 | 1997-12-16 | Gensia | Feedback controlled drug delivery system |
US5662622A (en) * | 1995-04-04 | 1997-09-02 | Cordis Corporation | Intravascular catheter |
BE1009277A3 (en) | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and method of preparation. |
US5911731A (en) | 1995-04-20 | 1999-06-15 | Target Therapeutics, Inc. | Anatomically shaped vasoocclusive devices |
US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
US5882444A (en) * | 1995-05-02 | 1999-03-16 | Litana Ltd. | Manufacture of two-way shape memory devices |
US5624508A (en) | 1995-05-02 | 1997-04-29 | Flomenblit; Josef | Manufacture of a two-way shape memory alloy and device |
US6689162B1 (en) | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
US5788558A (en) | 1995-11-13 | 1998-08-04 | Localmed, Inc. | Apparatus and method for polishing lumenal prostheses |
ES2236435T3 (en) * | 1996-01-11 | 2005-07-16 | C.R. Bard Inc. | RETENTION HEAD FOR TUBE ASSEMBLY TO ACCESS THE BODY. |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US5895398A (en) | 1996-02-02 | 1999-04-20 | The Regents Of The University Of California | Method of using a clot capture coil |
US5695506A (en) | 1996-02-06 | 1997-12-09 | Devices For Vascular Intervention | Catheter device with a flexible housing |
US5843117A (en) | 1996-02-14 | 1998-12-01 | Inflow Dynamics Inc. | Implantable vascular and endoluminal stents and process of fabricating the same |
US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US6592617B2 (en) | 1996-04-30 | 2003-07-15 | Boston Scientific Scimed, Inc. | Three-dimensional braided covered stent |
US6231544B1 (en) | 1996-05-14 | 2001-05-15 | Embol-X, Inc. | Cardioplegia balloon cannula |
US6270477B1 (en) * | 1996-05-20 | 2001-08-07 | Percusurge, Inc. | Catheter for emboli containment |
US6544276B1 (en) | 1996-05-20 | 2003-04-08 | Medtronic Ave. Inc. | Exchange method for emboli containment |
US5690120A (en) | 1996-05-24 | 1997-11-25 | Sarcos, Inc. | Hybrid catheter guide wire apparatus |
US5836066A (en) | 1996-07-22 | 1998-11-17 | Innovative Dynamics, Inc. | Process for the production of two-way shape memory alloys |
US5876568A (en) * | 1996-07-25 | 1999-03-02 | Kindersley; Peter | Safe and semi-automatic removal of heavy drum closures |
US5972019A (en) | 1996-07-25 | 1999-10-26 | Target Therapeutics, Inc. | Mechanical clot treatment device |
US6830577B2 (en) | 1996-07-26 | 2004-12-14 | Kensey Nash Corporation | System and method of use for treating occluded vessels and diseased tissue |
US6080170A (en) | 1996-07-26 | 2000-06-27 | Kensey Nash Corporation | System and method of use for revascularizing stenotic bypass grafts and other occluded blood vessels |
WO1998014232A1 (en) | 1996-10-03 | 1998-04-09 | Dubrul William R | Self coiling catheter |
US6279654B1 (en) | 1996-10-04 | 2001-08-28 | Donald E. Mosing | Method and multi-purpose apparatus for dispensing and circulating fluid in wellbore casing |
US5852277A (en) | 1996-10-24 | 1998-12-22 | Spectralytics, Inc. | Laser cutting tool for cutting elongated hollow workpieces |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US6977355B2 (en) | 1997-01-14 | 2005-12-20 | Walter Duley | Tailored blank |
BE1010858A4 (en) | 1997-01-16 | 1999-02-02 | Medicorp R & D Benelux Sa | Luminal endoprosthesis FOR BRANCHING. |
US8663311B2 (en) | 1997-01-24 | 2014-03-04 | Celonova Stent, Inc. | Device comprising biodegradable bistable or multistable cells and methods of use |
US6391044B1 (en) | 1997-02-03 | 2002-05-21 | Angioguard, Inc. | Vascular filter system |
US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
US6254633B1 (en) | 1997-02-12 | 2001-07-03 | Corvita Corporation | Delivery device for a medical device having a constricted region |
US5911737A (en) | 1997-02-28 | 1999-06-15 | The Regents Of The University Of California | Microfabricated therapeutic actuators |
FR2761964B1 (en) | 1997-04-10 | 1999-07-02 | Kvaerner Metals Clecim | COIL MANDREL FOR WINDING A TAPE PRODUCT AND USE THEREOF |
WO1998047447A1 (en) | 1997-04-23 | 1998-10-29 | Dubrul William R | Bifurcated stent and distal protection system |
US5868708A (en) * | 1997-05-07 | 1999-02-09 | Applied Medical Resources Corporation | Balloon catheter apparatus and method |
US5911734A (en) | 1997-05-08 | 1999-06-15 | Embol-X, Inc. | Percutaneous catheter and guidewire having filter and medical device deployment capabilities |
US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US6090118A (en) | 1998-07-23 | 2000-07-18 | Mcguckin, Jr.; James F. | Rotational thrombectomy apparatus and method with standing wave |
US6245103B1 (en) | 1997-08-01 | 2001-06-12 | Schneider (Usa) Inc | Bioabsorbable self-expanding stent |
US6174330B1 (en) * | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6860893B2 (en) * | 1997-08-29 | 2005-03-01 | Boston Scientific Scimed, Inc. | Stable coil designs |
US6395014B1 (en) | 1997-09-26 | 2002-05-28 | John A. Macoviak | Cerebral embolic protection assembly and associated methods |
US6066149A (en) | 1997-09-30 | 2000-05-23 | Target Therapeutics, Inc. | Mechanical clot treatment device with distal filter |
US5994667A (en) | 1997-10-15 | 1999-11-30 | Scimed Life Systems, Inc. | Method and apparatus for laser cutting hollow workpieces |
US20100030256A1 (en) * | 1997-11-12 | 2010-02-04 | Genesis Technologies Llc | Medical Devices and Methods |
US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
US6159165A (en) * | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US9254143B2 (en) | 1998-02-25 | 2016-02-09 | Revascular Therapeutics, Inc. | Guidewire for crossing occlusions or stenoses having a shapeable distal end |
US6019778A (en) * | 1998-03-13 | 2000-02-01 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6482217B1 (en) | 1998-04-10 | 2002-11-19 | Endicor Medical, Inc. | Neuro thrombectomy catheter |
US6511492B1 (en) * | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
EP1082072B8 (en) | 1998-06-04 | 2014-03-05 | New York University | Endovascular thin film devices for treating and preventing stroke |
US7105003B2 (en) | 1998-09-17 | 2006-09-12 | Karl Storz Gmbh & Co. Kg | Surgical instrument |
US6030406A (en) * | 1998-10-05 | 2000-02-29 | Origin Medsystems, Inc. | Method and apparatus for tissue dissection |
US6102890A (en) | 1998-10-23 | 2000-08-15 | Scimed Life Systems, Inc. | Catheter having improved proximal shaft design |
US6030586A (en) * | 1998-10-30 | 2000-02-29 | Kuan; Yu-Hung | Ozone generating and ozone/water mixing apparatus |
US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6262390B1 (en) | 1998-12-14 | 2001-07-17 | International Business Machines Corporation | Repair process for aluminum nitride substrates |
US6383204B1 (en) | 1998-12-15 | 2002-05-07 | Micrus Corporation | Variable stiffness coil for vasoocclusive devices |
US6165199A (en) | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
US7018401B1 (en) * | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US6146396A (en) | 1999-03-05 | 2000-11-14 | Board Of Regents, The University Of Texas System | Declotting method and apparatus |
US6428558B1 (en) | 1999-03-10 | 2002-08-06 | Cordis Corporation | Aneurysm embolization device |
US20040167613A1 (en) | 1999-03-11 | 2004-08-26 | Ofer Yodfat | Implantable stroke prevention device |
IL128938A0 (en) * | 1999-03-11 | 2000-02-17 | Mind Guard Ltd | Implantable stroke treating device |
US6673089B1 (en) * | 1999-03-11 | 2004-01-06 | Mindguard Ltd. | Implantable stroke treating device |
US6146370A (en) | 1999-04-07 | 2000-11-14 | Coaxia, Inc. | Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery |
US6350271B1 (en) * | 1999-05-17 | 2002-02-26 | Micrus Corporation | Clot retrieval device |
AU5179900A (en) | 1999-06-02 | 2000-12-18 | Sethel Interventional, Inc. | Intracorporeal occlusive device |
US6375668B1 (en) | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6458139B1 (en) | 1999-06-21 | 2002-10-01 | Endovascular Technologies, Inc. | Filter/emboli extractor for use in variable sized blood vessels |
US6589263B1 (en) | 1999-07-30 | 2003-07-08 | Incept Llc | Vascular device having one or more articulation regions and methods of use |
US6544279B1 (en) | 2000-08-09 | 2003-04-08 | Incept, Llc | Vascular device for emboli, thrombus and foreign body removal and methods of use |
US7306618B2 (en) | 1999-07-30 | 2007-12-11 | Incept Llc | Vascular device for emboli and thrombi removal and methods of use |
US6530939B1 (en) * | 1999-07-30 | 2003-03-11 | Incept, Llc | Vascular device having articulation region and methods of use |
US6203561B1 (en) * | 1999-07-30 | 2001-03-20 | Incept Llc | Integrated vascular device having thrombectomy element and vascular filter and methods of use |
ES2209503T3 (en) | 1999-08-27 | 2004-06-16 | Ev3 Inc. | FOLDING MEDICAL DEVICE. |
US6146404A (en) | 1999-09-03 | 2000-11-14 | Scimed Life Systems, Inc. | Removable thrombus filter |
JP2003509142A (en) * | 1999-09-15 | 2003-03-11 | アラダイム コーポレーション | Reduced aerosol pore structure |
US6749560B1 (en) | 1999-10-26 | 2004-06-15 | Circon Corporation | Endoscope shaft with slotted tube |
US6540722B1 (en) | 1999-12-30 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US6622604B1 (en) | 2000-01-31 | 2003-09-23 | Scimed Life Systems, Inc. | Process for manufacturing a braided bifurcated stent |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
EP1132058A1 (en) | 2000-03-06 | 2001-09-12 | Advanced Laser Applications Holding S.A. | Intravascular prothesis |
US6514273B1 (en) * | 2000-03-22 | 2003-02-04 | Endovascular Technologies, Inc. | Device for removal of thrombus through physiological adhesion |
US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
US20010031981A1 (en) * | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
US7344546B2 (en) | 2000-04-05 | 2008-03-18 | Pathway Medical Technologies | Intralumenal material removal using a cutting device for differential cutting |
US6569180B1 (en) * | 2000-06-02 | 2003-05-27 | Avantec Vascular Corporation | Catheter having exchangeable balloon |
US6554848B2 (en) | 2000-06-02 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Marker device for rotationally orienting a stent delivery system prior to deploying a curved self-expanding stent |
DE10028422C2 (en) * | 2000-06-06 | 2002-06-06 | Infineon Technologies Ag | Non-volatile NOR two-transistor semiconductor memory cell and associated NOR semiconductor memory device and method for their production |
US6652576B1 (en) | 2000-06-07 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Variable stiffness stent |
IL137326A0 (en) * | 2000-07-17 | 2001-07-24 | Mind Guard Ltd | Implantable braided stroke preventing device and method of manufacturing |
US7381198B2 (en) | 2000-08-23 | 2008-06-03 | Revascular Therapeutics, Inc. | Steerable distal support system |
US6589265B1 (en) | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
EP2130558A1 (en) * | 2000-11-13 | 2009-12-09 | Ensisheim Partners LLC | Methods and devices for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer |
US6679893B1 (en) * | 2000-11-16 | 2004-01-20 | Chestnut Medical Technologies, Inc. | Grasping device and method of use |
US20020091355A1 (en) | 2000-11-17 | 2002-07-11 | Ascend Medical, Inc. | Compliant delivery catheter |
US6517888B1 (en) | 2000-11-28 | 2003-02-11 | Scimed Life Systems, Inc. | Method for manufacturing a medical device having a coated portion by laser ablation |
BE1013757A6 (en) | 2000-12-12 | 2002-07-02 | Frid Noureddine | Luminal endoprosthesis MODULAR. |
US8192484B2 (en) | 2000-12-12 | 2012-06-05 | Cardiatis S.A. | Stent for blood flow improvement |
US20020194670A1 (en) | 2000-12-20 | 2002-12-26 | Hashemi Amin H. | Ventilation system for malodorous air removal |
US20040088037A1 (en) | 2000-12-27 | 2004-05-06 | American Medical Systems, Inc. | Method and apparatus for making a braided stent with spherically ended wires |
US6610077B1 (en) | 2001-01-23 | 2003-08-26 | Endovascular Technologies, Inc. | Expandable emboli filter and thrombectomy device |
US6563080B2 (en) | 2001-02-15 | 2003-05-13 | Scimed Life Systems, Inc. | Laser cutting of stents and other medical devices |
US6840950B2 (en) * | 2001-02-20 | 2005-01-11 | Scimed Life Systems, Inc. | Low profile emboli capture device |
US20020133111A1 (en) | 2001-03-19 | 2002-09-19 | Shadduck John H. | Neuro-thrombectomy catheter and method of use |
DE10118944B4 (en) | 2001-04-18 | 2013-01-31 | Merit Medical Systems, Inc. | Removable, essentially cylindrical implants |
US6837901B2 (en) * | 2001-04-27 | 2005-01-04 | Intek Technology L.L.C. | Methods for delivering, repositioning and/or retrieving self-expanding stents |
US6855153B2 (en) * | 2001-05-01 | 2005-02-15 | Vahid Saadat | Embolic balloon |
US6635070B2 (en) | 2001-05-21 | 2003-10-21 | Bacchus Vascular, Inc. | Apparatus and methods for capturing particulate material within blood vessels |
US6716207B2 (en) | 2001-05-22 | 2004-04-06 | Scimed Life Systems, Inc. | Torqueable and deflectable medical device shaft |
US20020188314A1 (en) | 2001-06-07 | 2002-12-12 | Microvena Corporation | Radiopaque distal embolic protection device |
US6612012B2 (en) | 2001-06-11 | 2003-09-02 | Cordis Neurovascular, Inc. | Method of manufacturing small profile medical devices |
US6521865B1 (en) * | 2001-06-14 | 2003-02-18 | Advanced Cardiovascular Systems, Inc. | Pulsed fiber laser cutting system for medical implants |
US6927359B2 (en) | 2001-06-14 | 2005-08-09 | Advanced Cardiovascular Systems, Inc. | Pulsed fiber laser cutting system for medical implants |
US20020198589A1 (en) | 2001-06-22 | 2002-12-26 | Leong Veronica Jade | Tessellated stent and method of manufacture |
US6585755B2 (en) | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
ATE347393T1 (en) | 2001-07-05 | 2006-12-15 | Precision Vascular Systems Inc | MEDICAL DEVICE HAVING A TORQUE-TRANSMITTING SOFT END PIECE AND METHOD FOR SHAPING IT |
US20030100945A1 (en) | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
US6978496B2 (en) | 2001-08-10 | 2005-12-27 | Taph, Llc | Portable water heater |
AU2002323407A1 (en) | 2001-08-24 | 2003-03-10 | University Of Virginia Patent Foundation | Reversible shape memory multifunctional structural designs and method of using and making the same |
US20050021075A1 (en) * | 2002-12-30 | 2005-01-27 | Bonnette Michael J. | Guidewire having deployable sheathless protective filter |
US20030114919A1 (en) | 2001-12-10 | 2003-06-19 | Mcquiston Jesse | Polymeric stent with metallic rings |
US20030135265A1 (en) | 2002-01-04 | 2003-07-17 | Stinson Jonathan S. | Prostheses implantable in enteral vessels |
US7029494B2 (en) | 2002-02-08 | 2006-04-18 | Scimed Life Systems, Inc. | Braided modular stent with hourglass-shaped interfaces |
US6773448B2 (en) * | 2002-03-08 | 2004-08-10 | Ev3 Inc. | Distal protection devices having controllable wire motion |
US20030176884A1 (en) | 2002-03-12 | 2003-09-18 | Marwane Berrada | Everted filter device |
US6914212B2 (en) | 2002-05-01 | 2005-07-05 | Becton Dickinson And Company | Method of making a needle and a needle |
US20030225448A1 (en) | 2002-05-28 | 2003-12-04 | Scimed Life Systems, Inc. | Polar radiopaque marker for stent |
US6710285B2 (en) * | 2002-06-01 | 2004-03-23 | First Call Explosive Solutions, Inc. | Laser system for slag removal |
US7172614B2 (en) | 2002-06-27 | 2007-02-06 | Advanced Cardiovascular Systems, Inc. | Support structures for embolic filtering devices |
US6696666B2 (en) * | 2002-07-03 | 2004-02-24 | Scimed Life Systems, Inc. | Tubular cutting process and system |
US20040004063A1 (en) * | 2002-07-08 | 2004-01-08 | Merdan Kenneth M. | Vertical stent cutting process |
US8425549B2 (en) | 2002-07-23 | 2013-04-23 | Reverse Medical Corporation | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US7303575B2 (en) | 2002-08-01 | 2007-12-04 | Lumen Biomedical, Inc. | Embolism protection devices |
US20040044391A1 (en) * | 2002-08-29 | 2004-03-04 | Stephen Porter | Device for closure of a vascular defect and method of treating the same |
US6818063B1 (en) | 2002-09-24 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for minimizing coating defects |
US7374564B2 (en) | 2002-10-08 | 2008-05-20 | Brown Joe D | Apparatus and method for causing deflection of a surgical instrument |
US7001425B2 (en) | 2002-11-15 | 2006-02-21 | Scimed Life Systems, Inc. | Braided stent method for its manufacture |
US20040098023A1 (en) | 2002-11-15 | 2004-05-20 | Scimed Life Systems, Inc. | Embolic device made of nanofibers |
US6696667B1 (en) * | 2002-11-22 | 2004-02-24 | Scimed Life Systems, Inc. | Laser stent cutting |
US6861615B2 (en) * | 2002-12-20 | 2005-03-01 | Kimberly-Clark Worldwide, Inc. | Method and system for cutting cores with a laser |
US7128752B2 (en) | 2002-12-23 | 2006-10-31 | Syntheon, Llc | Emboli and thrombi filter device and method of using the same |
US20040225186A1 (en) | 2003-01-29 | 2004-11-11 | Horne Guy E. | Composite flexible endoscope insertion shaft with tubular substructure |
JP2004261235A (en) | 2003-02-20 | 2004-09-24 | Kaneka Medix Corp | Medical wire device |
US6920677B2 (en) | 2003-02-27 | 2005-07-26 | Medtronic Vascular, Inc. | Method for manufacturing an endovascular support device |
US6862794B2 (en) * | 2003-03-03 | 2005-03-08 | Medtronic Ave, Inc. | Method for manufacturing an endovascular support device |
ATE416717T1 (en) | 2003-03-17 | 2008-12-15 | Ev3 Endovascular Inc | STENT WITH LAMINATED THIN FILM COMPOSITE |
US7300429B2 (en) | 2003-03-18 | 2007-11-27 | Catharos Medical Systems, Inc. | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
US20040193208A1 (en) | 2003-03-27 | 2004-09-30 | Scimed Life Systems, Inc. | Radiopaque embolic protection filter membrane |
US7001369B2 (en) | 2003-03-27 | 2006-02-21 | Scimed Life Systems, Inc. | Medical device |
US20040204737A1 (en) | 2003-04-11 | 2004-10-14 | Scimed Life Systems, Inc. | Embolic filter loop fabricated from composite material |
US6777647B1 (en) | 2003-04-16 | 2004-08-17 | Scimed Life Systems, Inc. | Combination laser cutter and cleaner |
WO2004100772A2 (en) | 2003-05-12 | 2004-11-25 | University Of Florida | Devices and methods for disruption and removal of luninal occlusions |
CN1852688A (en) * | 2003-05-19 | 2006-10-25 | 斯托特药物集团公司 | Tissue distention device and related methods for therapeutic intervention |
US7226473B2 (en) | 2003-05-23 | 2007-06-05 | Brar Balbir S | Treatment of stenotic regions |
US7093527B2 (en) | 2003-06-10 | 2006-08-22 | Surpass Medical Ltd. | Method and apparatus for making intraluminal implants and construction particularly useful in such method and apparatus |
US20050015110A1 (en) * | 2003-07-18 | 2005-01-20 | Fogarty Thomas J. | Embolization device and a method of using the same |
US7879062B2 (en) * | 2003-07-22 | 2011-02-01 | Lumen Biomedical, Inc. | Fiber based embolism protection device |
US7735493B2 (en) | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
US7476034B2 (en) * | 2003-08-28 | 2009-01-13 | Boston Scientific Scimed, Inc. | Dynamic bushing for medical device tubing |
US20050050624A1 (en) * | 2003-09-08 | 2005-03-10 | Pangramuyen Eugenio L. | Universal pneumatic-snake apparatus & method |
US7892188B2 (en) * | 2003-10-22 | 2011-02-22 | Hemosonics, Llc | Method and apparatus for characterization of clot formation |
US20050120471A1 (en) | 2003-12-09 | 2005-06-09 | Lim Howard T.S. | Toilet system attached a multi-purpose hand held water sprayer |
US20050131522A1 (en) | 2003-12-10 | 2005-06-16 | Stinson Jonathan S. | Medical devices and methods of making the same |
US7651514B2 (en) * | 2003-12-11 | 2010-01-26 | Boston Scientific Scimed, Inc. | Nose rider improvement for filter exchange and methods of use |
US20050149108A1 (en) | 2003-12-17 | 2005-07-07 | Microvention, Inc. | Implant delivery and detachment system and method |
US7030337B2 (en) | 2003-12-19 | 2006-04-18 | Honeywell International, Inc. | Hand-held laser welding wand having removable filler media delivery extension tips |
US7763011B2 (en) | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
DE102004008370B4 (en) | 2004-02-20 | 2006-06-01 | Siemens Ag | Catheter for performing and monitoring rotablation |
US8092483B2 (en) * | 2004-03-06 | 2012-01-10 | Medtronic, Inc. | Steerable device having a corewire within a tube and combination with a functional medical component |
EP1722697B1 (en) | 2004-03-08 | 2010-11-24 | Radius Medical Technologies, Inc. | Small-diameter snare |
US20080228209A1 (en) | 2004-03-08 | 2008-09-18 | Demello Richard M | System and method for removal of material from a blood vessel using a small diameter catheter |
US20070118165A1 (en) | 2004-03-08 | 2007-05-24 | Demello Jonathan R | System and method for removal of material from a blood vessel using a small diameter catheter |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US9039724B2 (en) | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US20050228417A1 (en) | 2004-03-26 | 2005-10-13 | Teitelbaum George P | Devices and methods for removing a matter from a body cavity of a patient |
US7105956B2 (en) | 2004-04-23 | 2006-09-12 | Aerotech, Inc. | High precision z-theta stage |
US7993387B2 (en) | 2004-05-14 | 2011-08-09 | Boston Scientific Scimed, Inc. | Stent with reduced weld profiles and a closed-end wire configuration |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US8628564B2 (en) * | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
AU2005247490B2 (en) | 2004-05-25 | 2011-05-19 | Covidien Lp | Flexible vascular occluding device |
US8147534B2 (en) | 2005-05-25 | 2012-04-03 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US20060206200A1 (en) | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US20050267510A1 (en) | 2004-05-26 | 2005-12-01 | Nasser Razack | Device for the endovascular treatment of intracranial aneurysms |
BE1016067A3 (en) * | 2004-06-03 | 2006-02-07 | Frid Noureddine | Luminal endoprosthesis FOR OBSTRUCTION OF ANEURYSM AND METHOD OF MANUFACTURING SUCH STENT. |
US20050277975A1 (en) | 2004-06-09 | 2005-12-15 | Usgi Medical Corp. | Methods and apparatus for creating a working space within a body lumen or cavity |
US20060004346A1 (en) * | 2004-06-17 | 2006-01-05 | Begg John D | Bend relief |
US7093416B2 (en) | 2004-06-17 | 2006-08-22 | 3M Innovative Properties Company | Cable and method of making the same |
US20060020286A1 (en) * | 2004-07-22 | 2006-01-26 | Volker Niermann | Device for filtering blood in a vessel with helical elements |
US7971333B2 (en) | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
DE102004040868A1 (en) | 2004-08-23 | 2006-03-09 | Miloslavski, Elina | Device for removing thrombi |
US20090105753A1 (en) | 2004-08-26 | 2009-04-23 | Prodesco, Inc. | Sutures and methods of making the same |
US20060047286A1 (en) * | 2004-08-31 | 2006-03-02 | Stephen West | Clot retrieval device |
US7641688B2 (en) | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
US8444668B2 (en) | 2004-09-17 | 2013-05-21 | DePuy Synthes Products, LLC | Expandable vascular occlusion device |
CA2585284C (en) | 2004-11-10 | 2013-07-23 | Boston Scientific Limited | Atraumatic stent with reduced deployment force, method for making the same and method and apparatus for deploying and positioning the stent |
EP1656963B1 (en) | 2004-11-10 | 2007-11-21 | Creganna Technologies Limited | Stent delivery catheter assembly |
US7989042B2 (en) * | 2004-11-24 | 2011-08-02 | Boston Scientific Scimed, Inc. | Medical devices with highly flexible coated hypotube |
US8771294B2 (en) | 2004-11-26 | 2014-07-08 | Biomerix Corporation | Aneurysm treatment devices and methods |
US20090297582A1 (en) | 2004-11-26 | 2009-12-03 | Biomerix Corporation | Vascular occlusion devices and methods |
US20060116713A1 (en) | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
US7828790B2 (en) | 2004-12-03 | 2010-11-09 | Boston Scientific Scimed, Inc. | Selectively flexible catheter and method of use |
JP5122975B2 (en) | 2004-12-13 | 2013-01-16 | スリーエム イノベイティブ プロパティズ カンパニー | Mounting mat and pollution control equipment using the same |
US9545300B2 (en) | 2004-12-22 | 2017-01-17 | W. L. Gore & Associates, Inc. | Filament-wound implantable devices |
US20060149312A1 (en) | 2004-12-30 | 2006-07-06 | Edward Arguello | Distal protection device with improved wall apposition |
US7837726B2 (en) | 2005-03-14 | 2010-11-23 | Abbott Laboratories | Visible endoprosthesis |
US20060229638A1 (en) | 2005-03-29 | 2006-10-12 | Abrams Robert M | Articulating retrieval device |
US20070233174A1 (en) | 2005-04-01 | 2007-10-04 | Gordon Hocking | Trapping Filter for Blood Vessel |
US7955345B2 (en) | 2005-04-01 | 2011-06-07 | Nexgen Medical Systems, Inc. | Thrombus removal system and process |
US8475487B2 (en) | 2005-04-07 | 2013-07-02 | Medrad, Inc. | Cross stream thrombectomy catheter with flexible and expandable cage |
US20060264904A1 (en) | 2005-05-09 | 2006-11-23 | Kerby Walter L | Medical device |
EP2666508B1 (en) | 2005-05-13 | 2019-07-24 | Boston Scientific Limited | Integrated stent repositioning and retrieval loop |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8285011B2 (en) * | 2005-06-02 | 2012-10-09 | M2S | Anatomical visualization and measurement system |
US20070027522A1 (en) | 2005-06-14 | 2007-02-01 | Chang Jean C | Stent delivery and guidewire systems |
US7622070B2 (en) | 2005-06-20 | 2009-11-24 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing an implantable polymeric medical device |
WO2007011353A2 (en) | 2005-07-19 | 2007-01-25 | Stout Medical Group L.P. | Embolic filtering method and apparatus |
US20070034615A1 (en) * | 2005-08-15 | 2007-02-15 | Klaus Kleine | Fabricating medical devices with an ytterbium tungstate laser |
US20070045255A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with an optimized process gas |
US7998132B2 (en) * | 2005-09-02 | 2011-08-16 | Boston Scientific Scimed, Inc. | Adjustable stiffness catheter |
US8663308B2 (en) | 2005-09-19 | 2014-03-04 | Cook Medical Technologies Llc | Graft with bioabsorbable support frame |
WO2007051183A1 (en) | 2005-10-28 | 2007-05-03 | Incept, Llc | Flared stents and apparatus and methods for delivering them |
US8157833B2 (en) | 2005-11-09 | 2012-04-17 | Applied Medical Resources Corporation | Trocars with advanced fixation |
US7955354B2 (en) | 2005-11-14 | 2011-06-07 | Occlutech Gmbh | Occlusion device and surgical instrument and method for its implantation/explantation |
DE102005059670A1 (en) | 2005-12-12 | 2007-06-14 | Phenox Gmbh | Device for removing thrombi from blood vessels |
US20070142903A1 (en) | 2005-12-15 | 2007-06-21 | Dave Vipul B | Laser cut intraluminal medical devices |
US8778008B2 (en) | 2006-01-13 | 2014-07-15 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of vascular abnormalities |
WO2007089897A2 (en) | 2006-02-01 | 2007-08-09 | The Cleveland Clinic Foundation | Inflatable-deflatable passive exercise unit |
EP1986568B1 (en) | 2006-02-03 | 2017-04-05 | Covidien LP | Methods and devices for restoring blood flow within blocked vasculature |
US9119651B2 (en) | 2006-02-13 | 2015-09-01 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US8152833B2 (en) | 2006-02-22 | 2012-04-10 | Tyco Healthcare Group Lp | Embolic protection systems having radiopaque filter mesh |
US7582101B2 (en) | 2006-02-28 | 2009-09-01 | Cordis Development Corporation | Heated mechanical detachment for delivery of therapeutic devices |
US20100010622A1 (en) * | 2006-03-13 | 2010-01-14 | Abbott Laboratories | Hybrid segmented endoprosthesis |
US8092508B2 (en) * | 2006-03-30 | 2012-01-10 | Stryker Corporation | Implantable medical endoprosthesis delivery system |
US20070228023A1 (en) | 2006-03-30 | 2007-10-04 | Klaus Kleine | Pulsed Synchronized Laser Cutting of Stents |
CN101049267B (en) * | 2006-04-03 | 2010-12-22 | 孟坚 | Medical use obstruction appliance |
US8414568B2 (en) | 2006-04-04 | 2013-04-09 | The Spectranetics Corporation | Laser-assisted guidewire having a variable stiffness shaft |
US8308712B2 (en) | 2006-04-19 | 2012-11-13 | Medronic Vascular, Inc. | Composite laminated catheter with flexible segment and method of making same |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
EP2018336B1 (en) | 2006-05-18 | 2018-08-22 | Applied Medical Resources Corporation | Method of making medical tubing having variable characteristics using thermal winding |
US20070288054A1 (en) | 2006-06-13 | 2007-12-13 | Tanaka Don A | Vascular thrombectomby apparatus and method of use |
US20080234722A1 (en) | 2006-06-14 | 2008-09-25 | Possis Medical, Inc. | Inferior vena cava filter on guidewire |
US7708704B2 (en) | 2006-07-31 | 2010-05-04 | Codman & Shurtleff, Pc | Interventional medical device component having an interrupted spiral section and method of making the same |
US7857008B2 (en) | 2006-08-24 | 2010-12-28 | Boston Scientific Scimed, Inc. | Medical device coating configuration and method for improved lubricity and durability |
MY163119A (en) | 2006-08-29 | 2017-08-15 | Genentech Inc | Use of tenecteplase for treating acute ischemic stroke |
US8419658B2 (en) | 2006-09-06 | 2013-04-16 | Boston Scientific Scimed, Inc. | Medical device including structure for crossing an occlusion in a vessel |
US8574219B2 (en) | 2006-09-18 | 2013-11-05 | Boston Scientific Scimed, Inc. | Catheter shaft including a metallic tapered region |
DE102006044831A1 (en) | 2006-09-20 | 2008-04-03 | Phenox Gmbh | Device for removing thrombi from blood vessels |
US20090248071A1 (en) | 2008-03-07 | 2009-10-01 | Alure Medical , Inc. | Minimally invasive tissue support |
US9149609B2 (en) | 2006-10-16 | 2015-10-06 | Embolitech, Llc | Catheter for removal of an organized embolic thrombus |
US20080269774A1 (en) | 2006-10-26 | 2008-10-30 | Chestnut Medical Technologies, Inc. | Intracorporeal Grasping Device |
US20080167679A1 (en) * | 2007-01-06 | 2008-07-10 | Papp John E | Cage and Sleeve Assembly for a Filtering Device |
US20080195230A1 (en) | 2007-02-09 | 2008-08-14 | Quijano Rodolfo C | Pericardial tissue sheet |
DE102007012964A1 (en) | 2007-03-06 | 2008-09-11 | Phenox Gmbh | Implant for influencing blood flow |
US8409270B2 (en) | 2007-04-16 | 2013-04-02 | Boston Scientific Scimed, Inc. | Radiopaque compositions, stents and methods of preparation |
EP2460476B1 (en) | 2007-04-16 | 2020-11-25 | Occlutech Holding AG | Occluder for closing a cardiac auricle and manufacturing method therefor |
US8779328B2 (en) | 2007-05-31 | 2014-07-15 | Abbott Cardiovascular Systems Inc. | Methods for laser cutting tubing to make medical devices |
US7932479B2 (en) | 2007-05-31 | 2011-04-26 | Abbott Cardiovascular Systems Inc. | Method for laser cutting tubing using inert gas and a disposable mask |
US8333897B2 (en) | 2007-05-31 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for laser cutting and processing tubing to make medical devices |
US8003157B2 (en) | 2007-06-15 | 2011-08-23 | Abbott Cardiovascular Systems Inc. | System and method for coating a stent |
US8048147B2 (en) | 2007-06-27 | 2011-11-01 | Aga Medical Corporation | Branched stent/graft and method of fabrication |
US8361138B2 (en) * | 2007-07-25 | 2013-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090112251A1 (en) | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US8409114B2 (en) | 2007-08-02 | 2013-04-02 | Boston Scientific Scimed, Inc. | Composite elongate medical device including distal tubular member |
US9808595B2 (en) * | 2007-08-07 | 2017-11-07 | Boston Scientific Scimed, Inc | Microfabricated catheter with improved bonding structure |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US9414842B2 (en) | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US8088140B2 (en) * | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US8236016B2 (en) | 2007-10-22 | 2012-08-07 | Atheromed, Inc. | Atherectomy devices and methods |
US20090125097A1 (en) | 2007-11-13 | 2009-05-14 | Medtronic Vascular, Inc. | Device and Method for Stent Graft Fenestration in Situ |
US20090157048A1 (en) | 2007-12-18 | 2009-06-18 | Boston Scientific Scimed, Inc. | Spiral cut hypotube |
US20090287120A1 (en) | 2007-12-18 | 2009-11-19 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Circulatory monitoring systems and methods |
US8555884B2 (en) | 2007-12-20 | 2013-10-15 | Paragon Space Development Corporation | Hazardous-environmental diving systems |
US8623071B2 (en) * | 2008-01-07 | 2014-01-07 | DePuy Synthes Products, LLC | Radiopaque super-elastic intravascular stent |
US8347772B2 (en) | 2008-01-08 | 2013-01-08 | Triaxial Structures, Inc. | Machine for alternating tubular and flat braid sections and method of using the machine |
US20090188269A1 (en) | 2008-01-25 | 2009-07-30 | Henkel Corporation | High pressure connection systems and methods for their manufacture |
US20090264985A1 (en) | 2008-04-17 | 2009-10-22 | Medtronic Vascular, Inc. | Branch Vessel Suture Stent System and Method |
ES2430117T3 (en) | 2008-04-21 | 2013-11-19 | Covidien Lp | Embolic braid ball devices and placement systems |
CA3048277C (en) | 2008-05-02 | 2022-06-21 | Sequent Medical Inc. | Filamentary devices for treatment of vascular defects |
US8114147B2 (en) | 2008-06-16 | 2012-02-14 | Boston Scientific Scimed, Inc. | Continuous double layered stent for migration resistance |
US20100023034A1 (en) * | 2008-06-19 | 2010-01-28 | Coherex Medical, Inc. | Clot retrieval method and device |
US20090318892A1 (en) | 2008-06-20 | 2009-12-24 | Maria Aboytes | Removable Core Implant Delivery Catheter |
US8945160B2 (en) | 2008-07-03 | 2015-02-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US8333796B2 (en) | 2008-07-15 | 2012-12-18 | Penumbra, Inc. | Embolic coil implant system and implantation method |
US7955449B2 (en) | 2008-07-17 | 2011-06-07 | Intek Technology, L.L.C. | Process for inducing a two-way shape memory effect in a device formed of a shape memory alloy and a device made by the process |
US8777976B2 (en) | 2008-07-22 | 2014-07-15 | Neuravi Limited | Clot capture systems and associated methods |
JP2011528943A (en) * | 2008-07-22 | 2011-12-01 | マイクロ セラピューティクス, インコーポレイテッド | Blood vessel remodeling device |
EP2334258B1 (en) | 2008-09-12 | 2012-11-28 | William A. Cook Australia Pty. Ltd. | Radiopaque reinforcing member |
US20100069948A1 (en) | 2008-09-12 | 2010-03-18 | Micrus Endovascular Corporation | Self-expandable aneurysm filling device, system and method of placement |
US20100069882A1 (en) | 2008-09-18 | 2010-03-18 | Boston Scientific Scimed, Inc. | Medical device with preferential bending |
US20100131000A1 (en) | 2008-11-21 | 2010-05-27 | Radius Medical Technologies, Inc. | System and method for removal of material from a blood vessel |
EP2379129B1 (en) | 2008-12-23 | 2017-09-13 | Silk Road Medical, Inc. | Methods and systems for treatment of acute ischemic stroke |
US8151682B2 (en) | 2009-01-26 | 2012-04-10 | Boston Scientific Scimed, Inc. | Atraumatic stent and method and apparatus for making the same |
US8361095B2 (en) * | 2009-02-17 | 2013-01-29 | Cook Medical Technologies Llc | Loop thrombectomy device |
US8740930B2 (en) | 2009-02-25 | 2014-06-03 | Medtronic Vascular, Inc. | Embolic filter device independent of treatment device |
AU2010217404A1 (en) | 2009-02-26 | 2011-09-29 | Depuy International Limited | Support structure implant for a bone cavity |
US8217303B2 (en) | 2009-03-16 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Dual gas laser cutting of medical devices |
KR20100119068A (en) | 2009-04-30 | 2010-11-09 | (주) 태웅메디칼 | Stent removal can strain the structure of the hooks |
US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
US8373090B2 (en) | 2009-09-04 | 2013-02-12 | Abbott Cardiovascular Systems Inc. | Method and apparatus to prevent stent damage caused by laser cutting |
US20110077620A1 (en) | 2009-09-30 | 2011-03-31 | Debeer Nicholas C | Guide Catheters |
GB2474866B8 (en) | 2009-10-29 | 2013-04-10 | Xiros Ltd | Knot slip resistant woven cord |
US20110152993A1 (en) | 2009-11-05 | 2011-06-23 | Sequent Medical Inc. | Multiple layer filamentary devices or treatment of vascular defects |
EP2501829B1 (en) | 2009-11-17 | 2018-06-20 | William B. Johnson | Improved fatigue-resistant nitinol instrument |
EP2539012B1 (en) | 2010-02-23 | 2018-01-24 | Covidien LP | Devices for vascular recanalization |
US20110238041A1 (en) | 2010-03-24 | 2011-09-29 | Chestnut Medical Technologies, Inc. | Variable flexibility catheter |
JP2013533171A (en) | 2010-04-19 | 2013-08-22 | エイティーエムアイ ビーブイビーエイ | Drain connector for fluid handling and storage vessels |
US9023070B2 (en) | 2010-05-13 | 2015-05-05 | Rex Medical, L.P. | Rotational thrombectomy wire coupler |
US8874434B2 (en) | 2010-06-02 | 2014-10-28 | Nec Laboratories America, Inc. | Method and apparatus for full natural language parsing |
US9561094B2 (en) * | 2010-07-23 | 2017-02-07 | Nfinium Vascular Technologies, Llc | Devices and methods for treating venous diseases |
US8556511B2 (en) | 2010-09-08 | 2013-10-15 | Abbott Cardiovascular Systems, Inc. | Fluid bearing to support stent tubing during laser cutting |
US20130066357A1 (en) | 2010-09-10 | 2013-03-14 | Maria Aboytes | Devices and methods for the treatment of vascular defects |
EP3354210B1 (en) | 2010-09-10 | 2022-10-26 | Covidien LP | Devices for the treatment of vascular defects |
US9867725B2 (en) | 2010-12-13 | 2018-01-16 | Microvention, Inc. | Stent |
GB2487970B (en) | 2011-02-11 | 2013-07-10 | Cook Medical Technologies Llc | Obstruction capture and removal device |
US8540750B2 (en) | 2011-03-23 | 2013-09-24 | St. Jude Medical Puerto Rico Llc | Dual lumen bond for vascular closure device and methods |
US8511214B2 (en) | 2011-04-21 | 2013-08-20 | Aga Medical Corporation | Tubular structure and method for making the same |
US9173736B2 (en) | 2011-04-28 | 2015-11-03 | Medtronic Vascular, Inc. | Method of making an endoluminal vascular prosthesis |
US20120283768A1 (en) | 2011-05-05 | 2012-11-08 | Sequent Medical Inc. | Method and apparatus for the treatment of large and giant vascular defects |
EP2706926B1 (en) | 2011-05-11 | 2016-11-30 | Covidien LP | Vascular remodeling device |
US20130030460A1 (en) * | 2011-07-26 | 2013-01-31 | Marks Michael P | Intravascular thromboembolectomy device and method using the same |
EP2751323B1 (en) | 2011-09-01 | 2020-03-25 | Cook Medical Technologies LLC | Method of forming a braided helical wire stent |
CN103957825B (en) | 2011-10-13 | 2018-12-07 | 阿瑟罗迈德公司 | Atherectomy device, system and method |
US8261648B1 (en) | 2011-10-17 | 2012-09-11 | Sequent Medical Inc. | Braiding mechanism and methods of use |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US20130240096A1 (en) | 2012-03-16 | 2013-09-19 | Gm Global Technology Operations Llc. | Phase change graded sma actuators |
US8932318B2 (en) | 2012-03-30 | 2015-01-13 | DePuy Synthes Products, LLC | Embolic coil detachment mechanism with polymer tether |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US8784434B2 (en) | 2012-11-20 | 2014-07-22 | Inceptus Medical, Inc. | Methods and apparatus for treating embolism |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
-
2007
- 2007-09-21 US US11/859,272 patent/US9034007B2/en active Active
-
2008
- 2008-09-22 WO PCT/US2008/010954 patent/WO2009038799A1/en active Application Filing
-
2015
- 2015-05-12 US US14/709,794 patent/US20150238303A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6695813B1 (en) * | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US6964670B1 (en) * | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US20030097094A1 (en) * | 2001-11-20 | 2003-05-22 | The Cleveland Clinic Foundation | Apparatus and method for eliminating dislodged thrombus |
US20050085846A1 (en) * | 2003-10-21 | 2005-04-21 | Scimed Life Systems, Inc. | Clot removal device |
US20070088383A1 (en) * | 2005-10-03 | 2007-04-19 | Cook Incorporated | Embolic protection device |
US20080147110A1 (en) * | 2006-12-19 | 2008-06-19 | Lalith Hiran Wijeratne | Embolic protection device with distal tubular member for improved torque response |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9314324B2 (en) | 2013-03-15 | 2016-04-19 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US9592068B2 (en) | 2013-03-15 | 2017-03-14 | Insera Therapeutics, Inc. | Free end vascular treatment systems |
US9750524B2 (en) | 2013-03-15 | 2017-09-05 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy systems |
US9833251B2 (en) | 2013-03-15 | 2017-12-05 | Insera Therapeutics, Inc. | Variably bulbous vascular treatment devices |
US9901435B2 (en) | 2013-03-15 | 2018-02-27 | Insera Therapeutics, Inc. | Longitudinally variable vascular treatment devices |
US10251739B2 (en) | 2013-03-15 | 2019-04-09 | Insera Therapeutics, Inc. | Thrombus aspiration using an operator-selectable suction pattern |
US10335260B2 (en) | 2013-03-15 | 2019-07-02 | Insera Therapeutics, Inc. | Methods of treating a thrombus in a vein using cyclical aspiration patterns |
US10342655B2 (en) | 2013-03-15 | 2019-07-09 | Insera Therapeutics, Inc. | Methods of treating a thrombus in an artery using cyclical aspiration patterns |
US10463468B2 (en) | 2013-03-15 | 2019-11-05 | Insera Therapeutics, Inc. | Thrombus aspiration with different intensity levels |
US11298144B2 (en) | 2013-03-15 | 2022-04-12 | Insera Therapeutics, Inc. | Thrombus aspiration facilitation systems |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US10751159B2 (en) | 2013-07-29 | 2020-08-25 | Insera Therapeutics, Inc. | Systems for aspirating thrombus during neurosurgical procedures |
Also Published As
Publication number | Publication date |
---|---|
US9034007B2 (en) | 2015-05-19 |
US20090082800A1 (en) | 2009-03-26 |
WO2009038799A1 (en) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9034007B2 (en) | Distal embolic protection devices with a variable thickness microguidewire and methods for their use | |
US10537418B2 (en) | Rapid exchange catheters and embolic protection devices | |
US11642150B2 (en) | Thrombectomy devices and treatment of acute ischemic stroke with thrombus engagement | |
JP6793147B2 (en) | Devices and methods for treating aneurysms | |
US10722255B2 (en) | Systems and methods for removing obstructive matter from body lumens and treating vascular defects | |
EP1348401B1 (en) | Low profile vascular filter system | |
US7637920B2 (en) | Double ended intravascular medical device | |
US8777977B2 (en) | Self-centering catheter and method of using same | |
JP2017523880A (en) | Occlusion bypass device and method with variable flexibility for bypassing intravascular occlusion | |
JP2004528126A (en) | Replaceable catheter | |
US20230355255A1 (en) | Methods and devices for treating vascular disease | |
US20240016633A1 (en) | Devices for accessing and treating venous sinuses and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INSERA THERAPEUTICS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INSERA THERAPEUTICS LLC;REEL/FRAME:035621/0362 Effective date: 20130626 Owner name: INSERA THERAPEUTICS LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JANARDHAN, VIKRAM;REEL/FRAME:035621/0335 Effective date: 20071202 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: KNOBBE, MARTENS, OLSON & BEAR, LLP, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:INSERA THERAPEUTICS, INC.;REEL/FRAME:053095/0350 Effective date: 20200610 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: INSERA THERAPEUTICS, INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:KNOBBE, MARTENS, OLSON & BEAR, LLP;REEL/FRAME:057454/0677 Effective date: 20210818 |